<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
    <channel>
        <title><![CDATA[Capricorn RSS]]></title>
        <link><![CDATA[https://capricorn.be/en/news/feed]]></link>
        <description><![CDATA[]]></description>
        <language>en-GB</language>
        <pubDate>2026-03-24T13:58:11+01:00</pubDate>

                    <item>
                <title><![CDATA[Bio-based Companies Rank in Global Cleantech 100]]></title>
                <link>https://capricorn.be/en/news_items/bio-based-companies-rank-in-global-cleantech-100</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/259</guid>
                <pubDate>2022-01-21T00:01:43+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Bluebee achieves HIPAA compliance]]></title>
                <link>https://capricorn.be/en/news_items/bluebee-achieves-hipaa-compliance</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/261</guid>
                <pubDate>2022-01-20T23:57:53+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Indigo announces successful Series A financing round]]></title>
                <link>https://capricorn.be/en/news_items/indigo-announces-successful-series-a-financing-round</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/264</guid>
                <pubDate>2022-01-09T10:48:08+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Ogeda announces fezolinetant as INN and issuance of US patent for ESN364]]></title>
                <link>https://capricorn.be/en/news_items/ogeda-announces-fezolinetant-inn-issuance-us-patent-esn364</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/265</guid>
                <pubDate>2021-10-28T10:03:20+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Capricorn Venture Partners announces first closing of its Capricorn Sustainable Chemistry Fund (CSCF) at € 50 million]]></title>
                <link>https://capricorn.be/en/news_items/capricorn-venture-partners-announces-first-closing-of-its-capricorn-sustainable-chemistry-fund-cscf-at-eur-50-million</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/267</guid>
                <pubDate>2022-01-09T14:01:06+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[NGDATA closes additional $9.4 million Series B Round for next generation Customer Experience Management]]></title>
                <link>https://capricorn.be/en/news_items/ngdata-closes-additional-94-million-series-b-round-for-next-generation-customer-experience-management</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/270</guid>
                <pubDate>2022-01-09T10:49:19+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Neurosurgeons from Germany and USA report on their clinical experience of using Nexstim NBS system]]></title>
                <link>https://capricorn.be/en/news_items/neurosurgeons-from-germany-and-usa-report-on-their-clinical-experience-of-using-nexstim-nbs-system</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/276</guid>
                <pubDate>2022-01-09T13:43:59+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Confo Therapeutics is awarded € 2.6 million in non-dilutive funding for the discovery of new fibrosis treatments and for expanding the use of its unique Confo® technology]]></title>
                <link>https://capricorn.be/en/news_items/confo-therapeutics-is-awarded-eur-26-million-in-non-dilutive-funding-for-the-discovery-of-new-fibrosis-treatments-and-for-expanding-the-use-of-its-unique-confo-technology</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/277</guid>
                <pubDate>2022-01-09T13:51:20+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Mainstay Medical starts commercialization of ReActiv8® for the treatment of Chronic Low Back Pain]]></title>
                <link>https://capricorn.be/en/news_items/mainstay-medical-starts-commercialization-of-reactiv8-for-the-treatment-of-chronic-low-back-pain</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/278</guid>
                <pubDate>2022-01-09T13:47:10+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Partnership initiated for the development of a Wood to Chemicals Reference Plant in Delfzijl]]></title>
                <link>https://capricorn.be/en/news_items/partnership-initiated-development-wood-chemicals-reference-plant-delfzijl</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/279</guid>
                <pubDate>2021-10-28T10:03:20+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Avantium announces intention to launch Initial Public Offering and listing on Euronext Amsterdam and Euronext Brussels]]></title>
                <link>https://capricorn.be/en/news_items/avantium-announces-intention-to-launch-initial-public-offering-and-listing-on-euronext-amsterdam-and-euronext-brussels</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/280</guid>
                <pubDate>2022-01-09T14:02:42+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Avantium launches its initial public offering on Euronext Amsterdam and Euronext Brussels]]></title>
                <link>https://capricorn.be/en/news_items/avantium-launches-its-initial-public-offering-on-euronext-amsterdam-and-euronext-brussels</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/284</guid>
                <pubDate>2022-01-09T14:03:13+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[FRX Polymers achieves ISO 9001:2015 Certification]]></title>
                <link>https://capricorn.be/en/news_items/frx-polymers-achieves-iso-90012015-certification</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/287</guid>
                <pubDate>2022-01-09T14:05:05+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Avantium raises € 103 million in successful Initial Public Offering]]></title>
                <link>https://capricorn.be/en/news_items/avantium-raises-eur-103-million-in-successful-initial-public-offering</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/288</guid>
                <pubDate>2022-01-09T14:05:24+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Astellas to acquire Ogeda SA]]></title>
                <link>https://capricorn.be/en/news_items/astellas-acquire-ogeda-sa</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/291</guid>
                <pubDate>2021-10-28T10:03:21+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Astellas to acquire Ogeda SA  Copy]]></title>
                <link>https://capricorn.be/en/news_items/astellas-acquire-ogeda-sa-copy</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/292</guid>
                <pubDate>2021-10-28T10:03:21+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[GreenFlame Heats Up Ahead of Grilling Season]]></title>
                <link>https://capricorn.be/en/news_items/greenflame-heats-ahead-grilling-season</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/293</guid>
                <pubDate>2021-10-28T10:03:21+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Bluebee Appoints two Independent Board Members]]></title>
                <link>https://capricorn.be/en/news_items/bluebee-appoints-two-independent-board-members</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/295</guid>
                <pubDate>2022-01-20T23:57:48+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Nexstim Plc updates the timeline for its supplementary E-FIT Phase III Trial in Stroke Rehabilitation]]></title>
                <link>https://capricorn.be/en/news_items/nexstim-plc-updates-timeline-supplementary-e-fit-phase-iii-trial-stroke-rehabilitation</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/299</guid>
                <pubDate>2022-01-09T13:45:33+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[New Chairman of the Board will accelerate US growth]]></title>
                <link>https://capricorn.be/en/news_items/new-chairman-of-the-board-will-accelerate-us-growth</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/300</guid>
                <pubDate>2021-10-28T10:03:21+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Bluebee and MediSapiens announce strategic partnership]]></title>
                <link>https://capricorn.be/en/news_items/bluebee-medisapiens-announce-strategic-partnership</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/301</guid>
                <pubDate>2022-01-20T23:57:42+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Industry Consortium receives funds (€25 million) for polyethylenfuranoate (PEF)]]></title>
                <link>https://capricorn.be/en/news_items/industry-consortium-receives-funds-e25-millio-polyethylenfuranoate-pef</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/302</guid>
                <pubDate>2021-10-28T10:03:21+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Nexstim Plc Files 510(k) Submission for its NBT® system for the Treatment of Depression with US FDA]]></title>
                <link>https://capricorn.be/en/news_items/nexstim-plc-files-510k-submission-for-its-nbt-system-for-the-treatment-of-depression-with-us-fda</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/305</guid>
                <pubDate>2022-01-09T13:45:44+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[FEops closes € 6 million Series B financing]]></title>
                <link>https://capricorn.be/en/news_items/feops-closes-eur-6-million-series-b-financing</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/308</guid>
                <pubDate>2022-01-09T10:50:29+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Ghent’s industrial Internet of Things company, Sensolus, raises € 2.75 million]]></title>
                <link>https://capricorn.be/en/news_items/ghents-industrial-internet-of-things-company-sensolus-raises-eur-275-million</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/310</guid>
                <pubDate>2022-01-09T10:51:14+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Confo Therapeutics enters into drug discovery collaboration with Lundbeck]]></title>
                <link>https://capricorn.be/en/news_items/confo-therapeutics-enters-into-drug-discovery-collaboration-with-lundbeck</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/311</guid>
                <pubDate>2022-01-09T13:51:42+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Sequana Medical announces publication of results of alfapump® Multicentre, Post-Marketing Surveillance Registry in Alimentary Pharmacology &amp; Therapeutics (AP&amp;T).]]></title>
                <link>https://capricorn.be/en/news_items/sequana-medical-announces-publication-of-results-of-alfapump-multicentre-post-marketing-surveillance-registry-in-alimentary-pharmacology-therapeutics-apt</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/312</guid>
                <pubDate>2022-01-09T13:54:56+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[FRX Polymers secures AU$ 15.15 million in pre-IPO mezzanine exchangeable notes]]></title>
                <link>https://capricorn.be/en/news_items/frx-polymers-secures-au-1515-million-in-pre-ipo-mezzanine-exchangeable-notes</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/313</guid>
                <pubDate>2021-10-28T10:03:21+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Capricorn Venture Partners makes first investment from its Capricorn Sustainable Chemistry Fund and completes ViroVet’s series A funding]]></title>
                <link>https://capricorn.be/en/news_items/capricorn-venture-partners-makes-first-investment-from-its-capricorn-sustainable-chemistry-fund-and-completes-virovets-series-a-funding</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/314</guid>
                <pubDate>2022-01-09T14:06:59+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[PacBio and Bluebee launch de novo genome assembly pipeline on the Bluebee analysis platform]]></title>
                <link>https://capricorn.be/en/news_items/pacbio-bluebee-launch-de-novo-genome-assembly-pipeline-bluebee-analysis-platform</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/315</guid>
                <pubDate>2022-01-20T23:57:36+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Arkite raises € 1.6 million to accelerate its European expansion]]></title>
                <link>https://capricorn.be/en/news_items/arkite-raises-eur-16-million-to-accelerate-its-european-expansion</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/316</guid>
                <pubDate>2022-01-09T10:52:28+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[iSTAR Medical completes enrolment of first-in-human MIGS trial]]></title>
                <link>https://capricorn.be/en/news_items/istar-medical-completes-enrolment-first-human-migs-trial</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/318</guid>
                <pubDate>2022-01-20T23:59:02+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Emmanuel Blin named Chairman of the Board at Noona Healthcare]]></title>
                <link>https://capricorn.be/en/news_items/emmanuel-blin-named-chairman-board-noona-healthcare</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/319</guid>
                <pubDate>2022-01-21T00:00:11+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Sequana Medical announces results of the MOSAIC trial data presented at 2017 AASLD]]></title>
                <link>https://capricorn.be/en/news_items/sequana-medical-announces-results-of-the-mosaic-trial-data-presented-at-2017-aasld</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/320</guid>
                <pubDate>2022-01-09T13:55:17+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Lexogen and Bluebee partner to bring the SLAMseq metabolic RNA sequencing data analysis pipeline to the users]]></title>
                <link>https://capricorn.be/en/news_items/lexogen-bluebee-partner-bring-slamseq-metabolic-rna-sequencing-data-analysis-pipeline-users</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/322</guid>
                <pubDate>2022-01-20T23:57:29+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Nexstim Plc appoints Steve Beller as Vice President and General Manager]]></title>
                <link>https://capricorn.be/en/news_items/nexstim-plc-appoints-steve-beller-vice-president-general-manager</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/323</guid>
                <pubDate>2022-01-09T13:45:19+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[NGDATA raises US$ 19 million to fuel global growth]]></title>
                <link>https://capricorn.be/en/news_items/ngdata-raises-us-19-million-to-fuel-global-growth</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/325</guid>
                <pubDate>2022-01-09T10:52:52+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Mainstay Medical announces positive outcome of interim analysis]]></title>
                <link>https://capricorn.be/en/news_items/mainstay-medical-announces-positive-outcome-of-interim-analysis</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/327</guid>
                <pubDate>2022-01-09T13:47:36+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Confo Therapeutics enters into drug discovery collaboration with Roche]]></title>
                <link>https://capricorn.be/en/news_items/confo-therapeutics-enters-into-drug-discovery-collaboration-with-roche</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/328</guid>
                <pubDate>2022-01-09T13:52:02+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Agendia and Bluebee Partner to Bring New NGS-Based MammaPrint®BluePrint® Breast Cancer Kit to Market]]></title>
                <link>https://capricorn.be/en/news_items/agendia-bluebee-partner-bring-new-ngs-based-mammaprintblueprint-breast-cancer-kit-market</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/329</guid>
                <pubDate>2022-01-20T23:57:25+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[DMC Biotechnologies announces first close of $1.75M equity financing led by Capricorn]]></title>
                <link>https://capricorn.be/en/news_items/dmc-biotechnologies-announces-first-close-of-175m-equity-financing-led-by-capricorn</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/331</guid>
                <pubDate>2022-01-09T14:07:28+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[ViroVet wins “start-up of the year” award]]></title>
                <link>https://capricorn.be/en/news_items/virovet-wins-start-up-of-the-year-award</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/333</guid>
                <pubDate>2022-01-09T14:07:49+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[LindaCare raises € 7M funding to improve remote patient monitoring for chronic disease management]]></title>
                <link>https://capricorn.be/en/news_items/lindacare-raises-eur-7m-funding-to-improve-remote-patient-monitoring-for-chronic-disease-management</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/334</guid>
                <pubDate>2022-01-09T10:55:06+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[New England Biolabs and Bluebee partner to deliver an end-to-end data analysis solution for NEBNext direct target enrichment]]></title>
                <link>https://capricorn.be/en/news_items/new-england-biolabs-bluebee-partner-deliver-end-end-data-analysis-solution-nebnext-direct-target-enrichment</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/338</guid>
                <pubDate>2022-01-20T23:57:21+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[FEops Elects Tom Fleming to its Board of Directors]]></title>
                <link>https://capricorn.be/en/news_items/feops-elects-tom-fleming-to-its-board-of-directors</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/339</guid>
                <pubDate>2022-01-09T11:10:57+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Mainstay Medical announces € 30 million financing new capital to complete US Pivotal ReActiv8-B clinical study and advance european commercialization]]></title>
                <link>https://capricorn.be/en/news_items/mainstay-medical-announces-eur-30-million-financing-new-capital-to-complete-us-pivotal-reactiv8-b-clinical-study-and-advance-european-commercialization</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/341</guid>
                <pubDate>2022-01-09T13:48:37+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Confo Therapeutics is awarded a € 1 million grant to increase its screening capabilities]]></title>
                <link>https://capricorn.be/en/news_items/confo-therapeutics-is-awarded-a-eur-1-million-grant-to-increase-its-screening-capabilities</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/342</guid>
                <pubDate>2022-01-09T13:52:27+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Sequana Medical announces publication of results of multicentre randomized controlled study]]></title>
                <link>https://capricorn.be/en/news_items/sequana-medical-announces-publication-of-results-of-multicentre-randomized-controlled-study</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/344</guid>
                <pubDate>2022-01-09T13:55:46+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[TCR signs Partnership Agreement with the Telematics’ Supplier Sensolus]]></title>
                <link>https://capricorn.be/en/news_items/tcr-signs-partnership-agreement-with-the-telematics-supplier-sensolus</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/349</guid>
                <pubDate>2022-01-09T11:10:40+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[iSTAR Medical’s MINIject delivers exceptional 6-month results]]></title>
                <link>https://capricorn.be/en/news_items/istar-medicals-miniject-delivers-exceptional-6-month-results</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/351</guid>
                <pubDate>2022-01-20T23:58:51+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Nexstim Plc – first NBT® system for depression ordered in the US]]></title>
                <link>https://capricorn.be/en/news_items/nexstim-plc-first-nbt-system-for-depression-ordered-in-the-us</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/352</guid>
                <pubDate>2022-01-09T13:45:07+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Sensolus launches next generation tracking devices in cooperation with Jorjin Technologies Inc and STMicroelectronics]]></title>
                <link>https://capricorn.be/en/news_items/sensolus-launches-next-generation-tracking-devices-in-cooperation-with-jorjin-technologies-inc-and-stmicroelectronics</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/353</guid>
                <pubDate>2022-01-09T10:57:32+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Bluebee achieves ISO 13485 Medical Device Quality Standard Certification]]></title>
                <link>https://capricorn.be/en/news_items/bluebee-achieves-iso-13485-medical-device-quality-standard-certification</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/355</guid>
                <pubDate>2022-01-20T23:55:30+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Mainstay Medical announces the completion of all implants in the ReActiv8-B Study]]></title>
                <link>https://capricorn.be/en/news_items/mainstay-medical-announces-the-completion-of-all-implants-in-the-reactiv8-b-study</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/358</guid>
                <pubDate>2022-01-09T13:49:10+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Noona and Duke Medicine to launch large study on I-O therapies in Oncology]]></title>
                <link>https://capricorn.be/en/news_items/noona-and-duke-medicine-to-launch-large-study-on-i-o-therapies-in-oncology</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/360</guid>
                <pubDate>2022-01-20T23:59:48+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[NGDATA accepted into G-Cloud 10 Framework]]></title>
                <link>https://capricorn.be/en/news_items/ngdata-accepted-into-g-cloud-10-framework</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/361</guid>
                <pubDate>2022-01-09T10:57:50+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Diagenode announces acquisition of Service Provider NXT-Dx to complement Epigenetics Assay Services]]></title>
                <link>https://capricorn.be/en/news_items/diagenode-announces-acquisition-of-service-provider-nxt-dx-to-complement-epigenetics-assay-services</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/363</guid>
                <pubDate>2022-01-21T00:00:41+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Capricorn Venture Partners announces SCG as limited partner in the Capricorn Sustainable Chemistry Fund]]></title>
                <link>https://capricorn.be/en/news_items/capricorn-venture-partners-announces-scg-as-limited-partner-in-the-capricorn-sustainable-chemistry-fund</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/365</guid>
                <pubDate>2022-01-09T14:08:45+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Capricorn Venture Partners leads financing round at c-LEcta and lays foundation for further corporate growth]]></title>
                <link>https://capricorn.be/en/news_items/capricorn-venture-partners-leads-financing-round-at-c-lecta-and-lays-foundation-for-further-corporate-growth</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/366</guid>
                <pubDate>2022-01-09T14:09:52+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Sequana Medical reports positive data on use of the alfapump® in malignant ascites patients at the International Gynecologic Cancer Society]]></title>
                <link>https://capricorn.be/en/news_items/sequana-medical-reports-positive-data-on-use-of-the-alfapump-in-malignant-ascites-patients-at-the-international-gynecologic-cancer-society</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/367</guid>
                <pubDate>2022-01-09T13:56:18+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Varian Expands cancer care portfolio with Noona Healthcare acquisition]]></title>
                <link>https://capricorn.be/en/news_items/varian-expands-cancer-care-portfolio-with-noona-healthcare-acquisition</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/372</guid>
                <pubDate>2022-01-20T23:59:38+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Sequana Medical establishes new corporate headquarters in Ghent, Belgium and raises € 8.5 million from leading Belgian investors including Newton Biocapital, PMV and SFPI-FPIM as well as existing shareholders]]></title>
                <link>https://capricorn.be/en/news_items/sequana-medical-establishes-new-corporate-headquarters-in-ghent-belgium-and-raises-eur-85-million-from-leading-belgian-investors-including-newton-biocapital-pmv-and-sfpi-fpim-as-well-as-existing-shareholders</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/373</guid>
                <pubDate>2022-01-09T13:56:45+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Capricorn’s Sustainable Chemistry Fund joins Black Bear funding round to solve the global waste tire problem and slash CO2]]></title>
                <link>https://capricorn.be/en/news_items/capricorns-sustainable-chemistry-fund-joins-black-bear-funding-round-to-solve-the-global-waste-tire-problem-and-slash-co2</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/375</guid>
                <pubDate>2021-12-29T10:58:15+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[UK NICE recommends use of Sequana&#039;s alfapump® for the treatment of refractory ascites caused by cirrhosis under special arrangements]]></title>
                <link>https://capricorn.be/en/news_items/uk-nice-recommends-use-of-sequanas-alfapump-for-the-treatment-of-refractory-ascites-caused-by-cirrhosis-under-special-arrangements</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/377</guid>
                <pubDate>2022-01-09T13:57:09+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[iSTAR Medical’s MINIject maintains exceptional results in first-in-human trial one year post-surgery (STAR-I)]]></title>
                <link>https://capricorn.be/en/news_items/istar-medicals-miniject-maintains-exceptional-results-in-first-in-human-trial-one-year-post-surgery-star-i</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/378</guid>
                <pubDate>2022-01-20T23:58:37+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Capricorn ICT Arkiv, Quest for Growth and Pamica invest in Leuven-based scale-up miaa Guard]]></title>
                <link>https://capricorn.be/en/news_items/capricorn-ict-arkiv-quest-for-growth-and-pamica-invest-in-leuven-based-scale-up-miaa-guard</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/380</guid>
                <pubDate>2022-01-09T10:58:53+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Capricorn Venture Partners holds final close of its Capricorn Sustainable Chemistry Fund at € 86.5 million adding new investors]]></title>
                <link>https://capricorn.be/en/news_items/capricorn-venture-partners-holds-final-close-of-its-capricorn-sustainable-chemistry-fund-at-e-86-5-million-adding-new-investors</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/382</guid>
                <pubDate>2022-01-09T14:10:22+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Bluebee receives Health Data Hosting (HDS) accreditation]]></title>
                <link>https://capricorn.be/en/news_items/bluebee-receives-health-data-hosting-hds-accreditation</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/385</guid>
                <pubDate>2022-01-20T23:55:13+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[LindaCare to debut ProPulse™ Cardiac Remote Monitoring Services]]></title>
                <link>https://capricorn.be/en/news_items/lindacare-to-debut-propulse-cardiac-remote-monitoring-services</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/386</guid>
                <pubDate>2022-01-09T10:59:37+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[FEops HEARTguideTM receives CE mark – not a joke]]></title>
                <link>https://capricorn.be/en/news_items/feops-heartguidetm-receives-ce-mark-not-a-joke</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/387</guid>
                <pubDate>2022-01-09T10:59:55+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Professor Paul Fitzgerald joins Nexstim’s Scientific Advisory Board]]></title>
                <link>https://capricorn.be/en/news_items/professor-paul-fitzgerald-joins-nexstims-scientific-advisory-board</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/389</guid>
                <pubDate>2022-01-09T13:44:54+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[LindaCare builds Powerhouse Remote-Monitoring Team: two world-renowned cardiac implantable device experts join as Senior Physician Consultants]]></title>
                <link>https://capricorn.be/en/news_items/lindacare-builds-powerhouse-remote-monitoring-team-two-world-renowned-cardiac-implantable-device-experts-join-as-senior-physician-consultants</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/391</guid>
                <pubDate>2022-01-09T11:00:12+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Confo Therapeutics raises € 30 million in Series A financing]]></title>
                <link>https://capricorn.be/en/news_items/confo-therapeutics-raises-eur-30-million-in-series-a-financing</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/392</guid>
                <pubDate>2022-01-09T13:53:00+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Soitec expands its engineered substrate portfolio into GaN (Gallium Nitride) with the acquisition of EpiGaN nv]]></title>
                <link>https://capricorn.be/en/news_items/soitec-expands-its-engineered-substrate-portfolio-into-gan-gallium-nitride-with-the-acquisition-of-epigan-nv</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/394</guid>
                <pubDate>2022-01-09T14:10:36+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Brain imaging AI leader icometrix raises US$ 18 million in new funding]]></title>
                <link>https://capricorn.be/en/news_items/brain-imaging-ai-leader-icometrix-raises-us-18-million-in-new-funding</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/395</guid>
                <pubDate>2022-01-09T11:00:31+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[NGDATA enables marketers to design and deliver data-driven, individualised campaigns in minutes, not weeks - Intelligent Engagement Platform unlocks the power of personalisation for every marketer – no data science degree needed]]></title>
                <link>https://capricorn.be/en/news_items/ngdata-enables-marketers-to-design-and-deliver-data-driven-individualised-campaigns-in-minutes-not-weeks-intelligent-engagement-platform-unlocks-the-power-of-personalisation-for-every-marketer</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/400</guid>
                <pubDate>2022-01-09T11:01:10+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Mainstay Medical announces completion of pre-submission meeting with FDA regarding  Pre-Market Approval (PMA) application for ReActiv8]]></title>
                <link>https://capricorn.be/en/news_items/mainstay-medical-announces-completion-of-pre-submission-meeting-with-fda-regarding-pre-market-approval-pma-application-for-reactiv8</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/402</guid>
                <pubDate>2022-01-09T13:50:06+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Arkite raises € 1.5 million to grow internationally]]></title>
                <link>https://capricorn.be/en/news_items/arkite-raises-e-1-5-million-to-grow-internationally</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/404</guid>
                <pubDate>2022-01-09T11:01:24+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[First closing of Capricorn Digital Growth Fund at €48 million]]></title>
                <link>https://capricorn.be/en/news_items/first-closing-of-capricorn-digital-growth-fund-at-e48-million</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/405</guid>
                <pubDate>2022-01-09T11:01:56+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Confo Therapeutics and DyNAbind announce drug discovery collaboration to identify novel GPCR-modulating compounds]]></title>
                <link>https://capricorn.be/en/news_items/confo-therapeutics-and-dynabind-announce-drug-discovery-collaboration-to-identify-novel-gpcr-modulating-compounds</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/406</guid>
                <pubDate>2022-01-09T13:38:36+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[DMC Biotechnologies announces first close of US$10.3M Series A financing led by Sofinnova Partners]]></title>
                <link>https://capricorn.be/en/news_items/dmc-biotechnologies-announces-first-close-of-us103m-series-a-financing-led-by-sofinnova-partners</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/408</guid>
                <pubDate>2021-12-23T21:41:36+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[iSTAR Medical’s MINIject shows consistent results at 18-month follow-up in first-in-human trial (STAR-I)]]></title>
                <link>https://capricorn.be/en/news_items/istar-medicals-miniject-shows-consistent-results-at-18-month-follow-up-in-first-in-human-trial-star-i</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/409</guid>
                <pubDate>2022-01-09T13:38:32+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Mainstay Medical announces completion of financing transactions]]></title>
                <link>https://capricorn.be/en/news_items/mainstay-medical-announces-completion-of-financing-transactions</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/410</guid>
                <pubDate>2021-12-23T21:40:42+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[LindaCare partners with Philips]]></title>
                <link>https://capricorn.be/en/news_items/lindacare-partners-with-philips</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/412</guid>
                <pubDate>2022-01-09T11:02:28+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Capricorn Venture Partners renamed to Capricorn Partners]]></title>
                <link>https://capricorn.be/en/news_items/capricorn-venture-partners-renamed-to-capricorn-partners</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/413</guid>
                <pubDate>2021-12-23T21:39:08+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[iSTAR Medical announces € 40 million Series C financing]]></title>
                <link>https://capricorn.be/en/news_items/istar-medical-announces-eur-40-million-series-c-financing</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/414</guid>
                <pubDate>2021-12-23T21:37:25+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Menarini Silicon Biosystems launches the MSBiosuite Bioinformatic platform, partners with BlueBee cloud-based solution automates NGS data analysis for liquid biopsy and FFPE workflows]]></title>
                <link>https://capricorn.be/en/news_items/menarini-silicon-biosystems-launches-the-msbiosuite-bioinformatic-platform-partners-with-bluebee-cloud-based-solution-automates-ngs-data-analysis-for-liquid-biopsy-and-ffpe-workflows</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/416</guid>
                <pubDate>2022-01-20T23:55:00+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[FierceBiotech names Confo Therapeutics as one of its “Fierce 15” Biotech Companies of 2019]]></title>
                <link>https://capricorn.be/en/news_items/fiercebiotech-names-confo-therapeutics-as-one-of-its-fierce-15-biotech-companies-of-2019</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/417</guid>
                <pubDate>2022-01-09T13:37:42+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Sequana Medical announces first patient enrolled in North American alfapump® pivotal study (POSEIDON)]]></title>
                <link>https://capricorn.be/en/news_items/sequana-medical-announces-first-patient-enrolled-in-north-american-alfapump-pivotal-study-poseidon</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/418</guid>
                <pubDate>2022-01-09T13:37:37+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[BlueBee establishes data center in mainland China, expanding global coverage for its Genomics Data Platform]]></title>
                <link>https://capricorn.be/en/news_items/bluebee-establishes-data-center-in-mainland-china-expanding-global-coverage-for-its-genomics-data-platform</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/421</guid>
                <pubDate>2022-01-20T23:54:49+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Confo Therapeutics reports grant of two key patents for ConfoBodies™]]></title>
                <link>https://capricorn.be/en/news_items/confo-therapeutics-reports-grant-of-two-key-patents-for-confobodies</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/425</guid>
                <pubDate>2022-01-09T13:37:31+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[FEops Awarded Euro 3.2 Million Grant From EU]]></title>
                <link>https://capricorn.be/en/news_items/feops-awarded-euro-32-million-grant-from-eu</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/428</guid>
                <pubDate>2021-12-23T21:32:23+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Sequana Medical announces first patient enrolled in RED DESERT – REpeated Dose alfapump® DSR study for Treatment of diuretic-resistant heart failure patients]]></title>
                <link>https://capricorn.be/en/news_items/sequana-medical-announces-first-patient-enrolled-in-red-desert-repeated-dose-alfapump-dsr-study-for-treatment-of-diuretic-resistant-heart-failure-patients</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/429</guid>
                <pubDate>2022-01-09T13:36:32+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Sequana Medical announces first-in-human data of Direct Sodium Removal (DSR) therapy published in Circulation]]></title>
                <link>https://capricorn.be/en/news_items/sequana-medical-announces-first-in-human-data-of-direct-sodium-removal-dsr-therapy-published-in-circulation</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/430</guid>
                <pubDate>2022-01-09T13:36:28+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[PREDICT-LAA trial enrolls first patient]]></title>
                <link>https://capricorn.be/en/news_items/predict-laa-trial-enrolls-first-patient</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/431</guid>
                <pubDate>2022-01-09T11:02:52+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Capricorn Partners invests in plant-based protein company Prolupin]]></title>
                <link>https://capricorn.be/en/news_items/capricorn-partners-invests-in-plant-based-protein-company-prolupin</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/434</guid>
                <pubDate>2021-12-23T21:28:46+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[icometrix early launching icompanion.ms]]></title>
                <link>https://capricorn.be/en/news_items/icometrix-early-launching-icompanionms</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/435</guid>
                <pubDate>2022-01-09T11:02:58+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[ViroVet to support COVID19 research and sample testing]]></title>
                <link>https://capricorn.be/en/news_items/virovet-to-support-covid19-research-and-sample-testing</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/436</guid>
                <pubDate>2022-01-09T14:10:53+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Nexstim reports promising clinical outcomes of first 55 patients completing SmartFocus® rTMS treatment of Major Depressive Disorder]]></title>
                <link>https://capricorn.be/en/news_items/nexstim-reports-promising-clinical-outcomes-of-first-55-patients-completing-smartfocus-rtms-treatment-of-major-depressive-disorder</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/437</guid>
                <pubDate>2022-01-09T13:36:23+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[icometrix launches the first CE-marked image AI solution for chest CT in COVID-19]]></title>
                <link>https://capricorn.be/en/news_items/icometrix-launches-the-first-ce-marked-image-ai-solution-for-chest-ct-in-covid-19</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/438</guid>
                <pubDate>2022-01-09T11:03:03+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[iSTAR Medical announces outstanding results with MIGS implant]]></title>
                <link>https://capricorn.be/en/news_items/istar-medical-announces-outstanding-results-with-migs-implant</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/439</guid>
                <pubDate>2021-12-23T21:23:02+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[icometrix welcomes Jennifer Young as Chief Commercial Officer]]></title>
                <link>https://capricorn.be/en/news_items/icometrix-welcomes-jennifer-young-as-chief-commercial-officer</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/440</guid>
                <pubDate>2022-01-09T11:03:10+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[TruGenomix Partners with BlueBee to create the next generation Behavioral Science Data Ecosystem]]></title>
                <link>https://capricorn.be/en/news_items/trugenomix-partners-with-bluebee-to-create-the-next-generation-behavioral-science-data-ecosystem</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/441</guid>
                <pubDate>2022-01-20T23:54:39+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[VOID Technologies raises £6 million in investment]]></title>
                <link>https://capricorn.be/en/news_items/void-technologies-raises-ps6-million-in-investment</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/442</guid>
                <pubDate>2021-12-23T21:22:38+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[icometrix nv appoints Dr Steve Rietiker as Chairman of the board]]></title>
                <link>https://capricorn.be/en/news_items/icometrix-nv-appoints-dr-steve-rietiker-as-chairman-of-the-board</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/443</guid>
                <pubDate>2022-01-09T11:03:17+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Seventure Partners joins ViroVet in series B funding]]></title>
                <link>https://capricorn.be/en/news_items/seventure-partners-joins-virovet-in-series-b-funding</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/444</guid>
                <pubDate>2021-12-23T21:18:12+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Confo Therapeutics appoints Paolo Vicini as Chief Development Officer]]></title>
                <link>https://capricorn.be/en/news_items/confo-therapeutics-appoints-paolo-vicini-as-chief-development-officer</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/445</guid>
                <pubDate>2022-01-09T13:36:12+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Mainstay Medical announces reimbursement approval for ReActiv8 in Australia]]></title>
                <link>https://capricorn.be/en/news_items/mainstay-medical-announces-reimbursement-approval-for-reactiv8-in-australia</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/446</guid>
                <pubDate>2022-01-09T13:36:02+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Confo Therapeutics expands Board with appointment of Rob Scott as Independent Director]]></title>
                <link>https://capricorn.be/en/news_items/confo-therapeutics-expands-board-with-appointment-of-rob-scott-as-independent-director</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/447</guid>
                <pubDate>2022-01-09T13:35:57+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Capricorn Digital Growth Fund announces first investment in Dutch AI company Gradyent while also adding new investors bringing the total fund size over € 50 million]]></title>
                <link>https://capricorn.be/en/news_items/capricorn-digital-growth-fund-announces-first-investment-in-dutch-ai-company-gradyent-while-also-adding-new-investors-bringing-the-total-fund-size-over-eur-50-million</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/448</guid>
                <pubDate>2021-12-23T21:11:54+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Illumina announced the acquisition of Bluebee, a portfolio company of both Capricorn ICT Arkiv and Quest for Growth]]></title>
                <link>https://capricorn.be/en/news_items/bluebee-2020-06-18</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/449</guid>
                <pubDate>2022-01-09T11:03:34+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Mainstay Medical announces US FDA approval of ReActiv8® Neurostimulation System for Chronic Low Back Pain]]></title>
                <link>https://capricorn.be/en/news_items/mainstay-medical-2020-06-22</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/450</guid>
                <pubDate>2022-01-20T16:18:08+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Indigo Diabetes concludes a €38 million round of financing]]></title>
                <link>https://capricorn.be/en/news_items/indigo-diabete-2020-07-27</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/451</guid>
                <pubDate>2022-01-09T11:05:27+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Capricorn Partners invests in Zeopore Technologies to bring its novel zeolite catalyst technologies to market]]></title>
                <link>https://capricorn.be/en/news_items/zeopore</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/453</guid>
                <pubDate>2021-12-23T21:09:40+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Scaled Access Now Available on Auth0 Marketplace]]></title>
                <link>https://capricorn.be/en/news_items/scaled-access-now-available-on-auth0-marketplace</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/455</guid>
                <pubDate>2022-01-09T11:05:42+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[NGDATA solidifies its strong position in the CDP market]]></title>
                <link>https://capricorn.be/en/news_items/ngdata-solidifies-its-strong-position-in-the-cdp-market</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/456</guid>
                <pubDate>2021-12-23T21:05:46+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Positive outcomes for iSTAR Medical’s MIGS MINIject shown in trials of over 130 glaucoma patients]]></title>
                <link>https://capricorn.be/en/news_items/positive-outcomes-for-istar-medicals-migs-miniject-shown-in-trials-of-over-130-glaucoma-patients</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/457</guid>
                <pubDate>2021-12-23T21:05:08+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Capricorn Fusion China Fund Joining forces around a shared investment belief]]></title>
                <link>https://capricorn.be/en/news_items/capricorn-fusion-china-fund-joining-forces-around-a-shared-investment-belief</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/458</guid>
                <pubDate>2021-12-23T21:04:37+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Nexstim continues to report promising results in quickly growing number of patients completing SmartFocus® rTMS treatment of Major Depressive Disorder]]></title>
                <link>https://capricorn.be/en/news_items/nexstim-continues-to-report-promising-results-in-quickly-growing-number-of-patients-completing-smartfocus-rtms-treatment-of-major-depressive-disorder</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/459</guid>
                <pubDate>2022-01-20T16:17:32+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Industrial IoT firm Sensolus secures € 3.5 million to enhance visibility in international supply chains]]></title>
                <link>https://capricorn.be/en/news_items/industrial-iot-firm-sensolus-secures-eur-35-million-to-enhance-visibility-in-international-supply-chains</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/460</guid>
                <pubDate>2022-01-09T11:06:57+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Confo Therapeutics announces selection of first product candidate and initiation of pre-clinical development]]></title>
                <link>https://capricorn.be/en/news_items/confo-therapeutics-announces-selection-of-first-product-candidate-and-initiation-of-pre-clinical-development</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/461</guid>
                <pubDate>2022-01-09T13:35:17+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[M&amp;A Awards Belgium: Panel of Judges nominates 15 deals - Bluebee/Illumina transaction is nominated]]></title>
                <link>https://capricorn.be/en/news_items/ma-awards-belgium-panel-of-judges-nominates-15-deals-bluebeeillumina-transaction-is-nominated</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/462</guid>
                <pubDate>2022-01-09T11:07:08+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[iSTAR Medical’s glaucoma device MINIject shows positive one-year results in European trial]]></title>
                <link>https://capricorn.be/en/news_items/istar-medicals-glaucoma-device-miniject-shows-positive-one-year-results-in-european-trial</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/463</guid>
                <pubDate>2021-12-23T20:58:23+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Capricorn welcomes Prof. Bart De Moor as Chairman of the Capricorn Digital Growth Fund]]></title>
                <link>https://capricorn.be/en/news_items/capricorn-welcomes-prof-bart-de-moor-as-chairman-of-the-capricorn-digital-growth-fund</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/464</guid>
                <pubDate>2022-01-09T11:07:29+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Capricorn Digital Growth Fund invests in Dutch cybersecurity scale-up EclecticIQ]]></title>
                <link>https://capricorn.be/en/news_items/capricorn-digital-growth-fund-invests-in-dutch-cybersecurity-scale-up-eclecticiq</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/465</guid>
                <pubDate>2022-01-09T11:07:56+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[New study presents impressive results of Nexstim SmartFocus® nTMS Language Mapping]]></title>
                <link>https://capricorn.be/en/news_items/new-study-presents-impressive-results-of-nexstim-smartfocus-ntms-language-mapping</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/467</guid>
                <pubDate>2021-12-23T20:45:23+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Mainstay Medical announces US$ 108 million equity financing transaction]]></title>
                <link>https://capricorn.be/en/news_items/mainstay-medical-announces-us-108-million-equity-financing-transaction</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/470</guid>
                <pubDate>2021-12-23T20:40:46+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Hologic acquires European Molecular diagnostic company Diagenode for approximately $159 million]]></title>
                <link>https://capricorn.be/en/news_items/hologic-acquires-european-molecular-diagnostic-company-diagenode-for-approximately-159-million</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/471</guid>
                <pubDate>2021-12-23T20:40:02+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[BNP Paribas Fortis Private Equity, Capricorn Fusion China Fund et al. invest in solid state lidar company, XenomatiX]]></title>
                <link>https://capricorn.be/en/news_items/bnp-paribas-fortis-private-equity-capricorn-fusion-china-fund-et-al-invest-in-solid-state-lidar-company-xenomatix</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/472</guid>
                <pubDate>2021-12-01T14:18:13+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Mainstay Medical announces commercial launch of ReActiv8® in Australia]]></title>
                <link>https://capricorn.be/en/news_items/mainstay-medical-announces-commercial-launch-of-reactiv8-in-australia</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/473</guid>
                <pubDate>2022-01-09T13:34:50+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Nexstim gives an update on its promising treatment results of Major Depressive Disorder]]></title>
                <link>https://capricorn.be/en/news_items/nexstim-gives-an-update-on-its-promising-treatment-results-of-major-depressive-disorder</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/474</guid>
                <pubDate>2022-01-09T13:34:38+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[DMC demonstrates full commercial scale at record speed]]></title>
                <link>https://capricorn.be/en/news_items/dmc-demonstrates-full-commercial-scale-at-record-speed</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/475</guid>
                <pubDate>2022-01-09T14:11:12+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Indigo Diabetes initiates first clinical study of its continuous glucose monitoring sensor]]></title>
                <link>https://capricorn.be/en/news_items/indigo-diabetes-initiates-first-clinical-study-of-its-continuous-glucose-monitoring-sensor</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/476</guid>
                <pubDate>2021-12-23T20:34:33+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[DMC CTO &amp; Co-Founder Mike Lynch publishes Technoeconomic Analysis (TEA) Calculator to take the guesswork out of bioprocess development]]></title>
                <link>https://capricorn.be/en/news_items/dmc-cto-co-founder-mike-lynch-publishes-technoeconomic-analysis-tea-calculator-to-take-the-guesswork-out-of-bioprocess-development</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/477</guid>
                <pubDate>2022-01-20T16:08:09+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Confo Therapeutics awarded € 1 million VLAIO grant for pre-clinical development of CFTX-1554, an AT2R modulator for the treatment of neuropathic pain]]></title>
                <link>https://capricorn.be/en/news_items/confo-therapeutics-awarded-eur-1-million-vlaio-grant-for-pre-clinical-development-of-cftx-1554-an-at2r-modulator-for-the-treatment-of-neuropathic-pain</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/478</guid>
                <pubDate>2022-01-20T16:06:54+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Capricorn Partners leads the series B capital increase at REIN4CED]]></title>
                <link>https://capricorn.be/en/news_items/capricorn-partners-leads-the-series-b-capital-increase-at-rein4ced</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/479</guid>
                <pubDate>2021-12-23T20:31:41+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Capricorn Partners and Southern Research Create Trillium Renewable Chemicals]]></title>
                <link>https://capricorn.be/en/news_items/capricorn-partners-and-southern-research-create-trillium-renewable-chemicals</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/481</guid>
                <pubDate>2022-01-20T16:15:39+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[DMC and Conagen partner for commercial manufacturing of L-alanine]]></title>
                <link>https://capricorn.be/en/news_items/dmc-and-conagen-partner-for-commercial-manufacturing-of-l-alanine</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/482</guid>
                <pubDate>2021-12-23T20:24:41+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Prolupin announces Paul Denayer as new CEO]]></title>
                <link>https://capricorn.be/en/news_items/prolupin-announces-paul-denayer-as-new-ceo</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/483</guid>
                <pubDate>2021-12-23T20:20:00+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Indigo Diabetes appoints Paul Moraviec as Chairman of the Board]]></title>
                <link>https://capricorn.be/en/news_items/indigo-diabetes-appoints-paul-moraviec-as-chairman-of-the-board</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/485</guid>
                <pubDate>2022-01-09T11:09:00+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[DMC’s Downstream Processing Proven At Scale]]></title>
                <link>https://capricorn.be/en/news_items/dmcs-downstream-processing-proven-at-scale</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/486</guid>
                <pubDate>2022-01-09T14:11:32+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Impressive new study results suggest potential new therapeutic use for Nexstim SmartFocus® nTMS in postsurgical rehabilitation of Paresis]]></title>
                <link>https://capricorn.be/en/news_items/impressive-new-study-results-suggest-potential-new-therapeutic-use-for-nexstim-smartfocus-ntms-in-postsurgical-rehabilitation-of-paresis</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/487</guid>
                <pubDate>2022-01-20T16:07:35+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Black Bear Carbon raises € 7.5 million in a first closing for its new flagship plant]]></title>
                <link>https://capricorn.be/en/news_items/black-bear-carbon-raises-eur-75-million-in-a-first-closing-for-its-new-flagship-plant</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/488</guid>
                <pubDate>2022-01-20T16:16:11+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Nexstim granted authorization for commercial distribution of NBS system in Australia]]></title>
                <link>https://capricorn.be/en/news_items/nexstim-granted-authorization-for-commercial-distribution-of-nbs-system-in-australia</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/489</guid>
                <pubDate>2022-01-20T16:15:08+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Nexstim extends agreement with Canadian distributor and receives order for three NBT® systems]]></title>
                <link>https://capricorn.be/en/news_items/nexstim-extends-agreement-with-canadian-distributor-and-receives-order-for-three-nbt-systems</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/490</guid>
                <pubDate>2022-01-20T16:11:22+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Capricorn Fusion China Fund announces intermediate closing bringing commitments to over € 30 million]]></title>
                <link>https://capricorn.be/en/news_items/cfcf2021-04-30</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/491</guid>
                <pubDate>2022-01-20T16:10:47+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[NGDATA Joins Growing Ecosystem of Partners Supporting the IBM Cloud for Financial Services]]></title>
                <link>https://capricorn.be/en/news_items/ngdata-joins-growing-ecosystem-of-partners-supporting-the-ibm-cloud-for-financial-services</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/492</guid>
                <pubDate>2022-01-20T16:14:10+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Game-changing catalytic dewaxing: Zeopore reaches 30°C cloud point improvement while keeping diesel yield loss under 2wt%, confirmed in a high throughput testing campaign at hte GmbH]]></title>
                <link>https://capricorn.be/en/news_items/game-changing-catalytic-dewaxing-zeopore-reaches-30c-cloud-point-improvement-while-keeping-diesel-yield-loss-under-2wt-confirmed-in-a-high-throughput-testing-campaign-at-hte-gmbh</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/493</guid>
                <pubDate>2022-01-20T16:06:07+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[iSTAR Medical receives US FDA approval to start pivotal trial for MINIject in glaucoma patients]]></title>
                <link>https://capricorn.be/en/news_items/istar-medical-receives-us-fda-approval-to-start-pivotal-trial-for-miniject-in-glaucoma-patients</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/494</guid>
                <pubDate>2022-01-20T16:13:01+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Spectricity raises € 14 million to deliver industry leading hyperspectral sensing to mobile and consumer devices]]></title>
                <link>https://capricorn.be/en/news_items/spectricity-raises-eur-14-million-to-deliver-industry-leading-hyperspectral-sensing-to-mobile-and-consumer-devices</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/495</guid>
                <pubDate>2022-01-20T16:08:41+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Black Bear &amp; HELM sign Memorandum of Understanding to bring sustainable Carbon Black to the market by 2023]]></title>
                <link>https://capricorn.be/en/news_items/black-bear-helm-sign-memorandum-of-understanding-to-bring-sustainable-carbon-black-to-the-market-by-2023</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/496</guid>
                <pubDate>2022-01-20T16:10:00+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Capricorn Partners and FPIM-SFPI lead financing round at Qpinch]]></title>
                <link>https://capricorn.be/en/news_items/capricorn-partners-and-fpim-sfpi-lead-financing-round-at-qpinch</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/497</guid>
                <pubDate>2022-01-27T17:43:51+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[&quot;Dit wordt het decennium van de neurowetenschap&quot;]]></title>
                <link>https://capricorn.be/en/news_items/dit-wordt-het-decennium-van-de-neurowetenschap</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/498</guid>
                <pubDate>2021-12-23T19:57:20+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Aconterra forms Strategic Partnership with Capricorn and invests € 10 million in Capricorn Digital Growth Fund]]></title>
                <link>https://capricorn.be/en/news_items/aconterra-forms-strategic-partnership-with-capricorn-and-invests-eur-10-million-in-capricorn-digital-growth-fund</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/499</guid>
                <pubDate>2022-01-20T16:12:23+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[FEops HEARTguide authorized by FDA for unprecedented LAAo planning capabilities]]></title>
                <link>https://capricorn.be/en/news_items/feops-heartguide-authorized-by-fda-for-unprecedented-laao-planning-capabilities</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/500</guid>
                <pubDate>2022-01-20T16:14:40+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[FEops appoints Digital Health expert Euan Thomson to its Board of Directors]]></title>
                <link>https://capricorn.be/en/news_items/feops-appoints-digital-health-expert-euan-thomson-to-its-board-of-directors</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/501</guid>
                <pubDate>2022-01-20T16:16:39+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Capricorn Partners leads investment round in  Belgian digital health tech company DEO]]></title>
                <link>https://capricorn.be/en/news_items/capricorn-partners-leads-investment-round-in-belgian-digital-health-tech-company-deo</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/502</guid>
                <pubDate>2022-01-20T16:13:35+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Quest for Growth invests 1.9 million euro in Qpinch]]></title>
                <link>https://capricorn.be/en/news_items/quest-for-growth-invests-19-million-euro-in-qpinch</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/504</guid>
                <pubDate>2022-01-21T15:38:20+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[NAV per 30/09/2021]]></title>
                <link>https://capricorn.be/en/news_items/nav-per-30092021</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/505</guid>
                <pubDate>2022-01-20T21:47:31+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[NAV per 31/10/2021]]></title>
                <link>https://capricorn.be/en/news_items/nav-per-31102021</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/509</guid>
                <pubDate>2022-01-20T21:46:02+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Quest for Growth wins ABAF-BVFA award]]></title>
                <link>https://capricorn.be/en/news_items/quest-for-growth-wins-abaf-bvfa-award</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/510</guid>
                <pubDate>2021-12-23T20:51:48+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Quest for Growth invests 1.7 million USD in DMC]]></title>
                <link>https://capricorn.be/en/news_items/quest-for-growth-invests-17-million-usd-in-dmc</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/511</guid>
                <pubDate>2021-12-23T20:50:31+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[NAV per 30/11/2021]]></title>
                <link>https://capricorn.be/en/news_items/nav-per-30112021</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/512</guid>
                <pubDate>2022-01-20T21:45:50+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[NAV per 31/08/2021]]></title>
                <link>https://capricorn.be/en/news_items/nav-per-31082021</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/513</guid>
                <pubDate>2022-01-20T21:45:39+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[NAV per 31/07/2021]]></title>
                <link>https://capricorn.be/en/news_items/nav-per-31072021</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/514</guid>
                <pubDate>2022-01-20T21:45:02+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Quest for Growth business update 30 September 2021]]></title>
                <link>https://capricorn.be/en/news_items/quest-for-growth-business-update-30-september-2021</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/515</guid>
                <pubDate>2022-01-21T13:45:49+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Acquisition of HalioDx closed]]></title>
                <link>https://capricorn.be/en/news_items/acquisition-of-haliodx-closed</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/516</guid>
                <pubDate>2022-01-13T11:03:06+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Quest for Growth halfjaarverslag]]></title>
                <link>https://capricorn.be/en/news_items/quest-for-growth-halfjaarverslag</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/517</guid>
                <pubDate>2022-01-21T13:50:41+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Veracyte to acquire HalioDx]]></title>
                <link>https://capricorn.be/en/news_items/veracyte-to-acquire-haliodx</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/518</guid>
                <pubDate>2022-01-13T11:01:48+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[NAV per 30/06/2021]]></title>
                <link>https://capricorn.be/en/news_items/nav-per-30062021</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/519</guid>
                <pubDate>2022-01-20T21:44:50+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[NAV per 31/05/2021]]></title>
                <link>https://capricorn.be/en/news_items/nav-per-31052021</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/520</guid>
                <pubDate>2022-01-20T21:44:37+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[NAV per 31/12/2020]]></title>
                <link>https://capricorn.be/en/news_items/nav-per-31122020</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/521</guid>
                <pubDate>2022-01-20T21:44:07+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[NAV per 31/01/2021]]></title>
                <link>https://capricorn.be/en/news_items/nav-per-31012021</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/522</guid>
                <pubDate>2022-01-20T21:43:58+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[NAV per 28/02/2021]]></title>
                <link>https://capricorn.be/en/news_items/nav-per-28022021</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/524</guid>
                <pubDate>2022-01-20T21:42:50+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[NAV per 31/03/2021]]></title>
                <link>https://capricorn.be/en/news_items/nav-per-31032021</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/525</guid>
                <pubDate>2022-01-20T21:42:32+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[NAV per 30/04/2021]]></title>
                <link>https://capricorn.be/en/news_items/nav-per-30042021</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/526</guid>
                <pubDate>2022-01-21T15:37:02+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[QfG invests 7.6 million € in Capricorn Fusion China Fund]]></title>
                <link>https://capricorn.be/en/news_items/qfg-invests-76-million-eur-in-capricorn-fusion-china-fund</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/527</guid>
                <pubDate>2022-05-09T15:24:23+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Quest for Growth Distribution of EUR 0.40 per share is approved]]></title>
                <link>https://capricorn.be/en/news_items/quest-for-growth-distribution-of-eur-040-per-share-is-approved</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/528</guid>
                <pubDate>2022-01-21T13:50:15+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[QfG invests in REIN4CED]]></title>
                <link>https://capricorn.be/en/news_items/qfg-invests-in-rein4ced</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/530</guid>
                <pubDate>2021-12-27T21:11:40+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Quest for Growth Positive developments in unquoted portfolio]]></title>
                <link>https://capricorn.be/en/news_items/quest-for-growth-positive-developments-in-unquoted-portfolio</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/531</guid>
                <pubDate>2022-01-21T13:49:44+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Jos Clijsters proposed as director]]></title>
                <link>https://capricorn.be/en/news_items/jos-clijsters-proposed-as-director</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/532</guid>
                <pubDate>2022-01-21T13:49:06+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[NAV per 31/12/2019]]></title>
                <link>https://capricorn.be/en/news_items/nav-per-31122019</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/533</guid>
                <pubDate>2022-01-20T21:41:54+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Quest for Growth Annual results 2019]]></title>
                <link>https://capricorn.be/en/news_items/quest-for-growth-annual-results-2019</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/534</guid>
                <pubDate>2022-01-21T13:48:39+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[NAV per 31/01/2020]]></title>
                <link>https://capricorn.be/en/news_items/nav-per-31012020</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/535</guid>
                <pubDate>2022-01-20T21:40:56+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Quest for Growth General Shareholders&#039; Meeting]]></title>
                <link>https://capricorn.be/en/news_items/quest-for-growth-general-shareholders-meeting</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/536</guid>
                <pubDate>2022-01-21T13:48:08+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[NAV per 29/02/2020]]></title>
                <link>https://capricorn.be/en/news_items/nav-per-29022020</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/537</guid>
                <pubDate>2022-01-20T21:40:14+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[NAV per 31/12/2021]]></title>
                <link>https://capricorn.be/en/news_items/nav-per-31122021</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/538</guid>
                <pubDate>2022-01-20T21:39:59+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Quest for Growth invests in Prolupin]]></title>
                <link>https://capricorn.be/en/news_items/quest-for-growth-invests-in-prolupin</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/539</guid>
                <pubDate>2022-05-09T15:23:41+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[NAV per 31/03/2020]]></title>
                <link>https://capricorn.be/en/news_items/nav-per-31032020</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/540</guid>
                <pubDate>2022-01-20T21:39:05+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Quest for Growth Quarterly report Q1 2020]]></title>
                <link>https://capricorn.be/en/news_items/quest-for-growth-quarterly-report-q1-2020</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/541</guid>
                <pubDate>2022-01-21T13:47:42+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[NAV per 30/04/2020]]></title>
                <link>https://capricorn.be/en/news_items/nav-per-30042020</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/543</guid>
                <pubDate>2022-01-20T21:38:46+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[NAV per 31/05/2020]]></title>
                <link>https://capricorn.be/en/news_items/nav-per-31052020</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/544</guid>
                <pubDate>2022-01-20T21:37:58+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Acquisition BlueBee has positive impact on NAV]]></title>
                <link>https://capricorn.be/en/news_items/acquisition-bluebee-has-positive-impact-on-nav</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/545</guid>
                <pubDate>2022-05-09T15:22:26+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[NAV per 30/06/2020]]></title>
                <link>https://capricorn.be/en/news_items/nav-per-30062020</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/546</guid>
                <pubDate>2022-01-20T21:37:33+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Quest for Growth semi-annual report January-June 2020]]></title>
                <link>https://capricorn.be/en/news_items/quest-for-growth-semi-annual-report-january-june-2020</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/547</guid>
                <pubDate>2022-05-09T15:23:12+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[NAV per 31/07/2020]]></title>
                <link>https://capricorn.be/en/news_items/nav-per-31072020</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/548</guid>
                <pubDate>2022-01-20T21:37:10+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[NAV per 31/08/2020]]></title>
                <link>https://capricorn.be/en/news_items/nav-per-31082020</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/549</guid>
                <pubDate>2022-01-20T21:36:52+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[NAV per 30/09/2020]]></title>
                <link>https://capricorn.be/en/news_items/nav-per-30092020</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/550</guid>
                <pubDate>2022-01-20T21:35:38+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Quest for Growth Quarterly update Q3 2020]]></title>
                <link>https://capricorn.be/en/news_items/quest-for-growth-quarterly-update-q3-2020</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/551</guid>
                <pubDate>2022-01-21T13:46:43+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[NAV per 31/10/2020]]></title>
                <link>https://capricorn.be/en/news_items/nav-per-31102020</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/552</guid>
                <pubDate>2022-01-20T21:35:18+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Quest for Growth invests 2 million euro in EclecticIQ]]></title>
                <link>https://capricorn.be/en/news_items/quest-for-growth-invests-2-million-euro-in-eclecticiq</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/553</guid>
                <pubDate>2022-05-09T15:21:29+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[NAV per 30/11/2020]]></title>
                <link>https://capricorn.be/en/news_items/nav-per-30112020</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/554</guid>
                <pubDate>2022-01-20T21:34:52+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[DMC Appoints Ashley Jenkins as CFO]]></title>
                <link>https://capricorn.be/en/news_items/dmc-appoints-ashley-jenkins-as-cfo</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/555</guid>
                <pubDate>2022-01-20T16:04:58+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Solvay to collaborate with Trillium on bio-based acrylonitrile for carbon fiber applications]]></title>
                <link>https://capricorn.be/en/news_items/solvay-to-collaborate-with-trillium-on-bio-based-acrylonitrile-for-carbon-fiber-applications</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/556</guid>
                <pubDate>2022-02-15T10:00:52+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Article on Circular Bioeconomy in “Platform Life Sciences” of November 2021]]></title>
                <link>https://capricorn.be/en/news_items/article-on-circular-bioeconomy-in-platform-life-sciences-of-november-2021</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/557</guid>
                <pubDate>2022-01-21T15:36:19+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Article in Bio Market Insights: “Forget the hype. Invest in technology that makes sense”]]></title>
                <link>https://capricorn.be/en/news_items/article-in-bio-market-insights-forget-the-hype-invest-in-technology-that-makes-sense</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/558</guid>
                <pubDate>2022-01-20T16:01:40+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Capricorn Further Invests in DMC Series B]]></title>
                <link>https://capricorn.be/en/news_items/capricorn-further-invests-in-dmc-series-b</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/559</guid>
                <pubDate>2022-01-20T15:58:34+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Archive Quest for Growth]]></title>
                <link>https://capricorn.be/en/news_items/archive-quest-for-growth</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/560</guid>
                <pubDate>2022-01-21T16:33:14+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Capricorn Partners prepares its future further with a restyled logo and a new website]]></title>
                <link>https://capricorn.be/en/news_items/capricorn-partners-prepares-its-future-further-with-a-restyled-logo-and-a-new-website</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/561</guid>
                <pubDate>2022-02-15T09:52:35+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Quest for Growth records a profit of € 33 million in 2021 and proposes a dividend of € 1.02]]></title>
                <link>https://capricorn.be/en/news_items/quest-for-growth-records-a-profit-of-eur-33-million-in-2021-and-proposes-a-dividend-of-eur-102</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/562</guid>
                <pubDate>2022-01-27T17:43:08+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Subsequent close of Series B financing, total raised US$ 39 million]]></title>
                <link>https://capricorn.be/en/news_items/subsequent-close-of-series-b-financing-total-raised-us-39-million</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/563</guid>
                <pubDate>2022-01-31T09:40:05+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[NAV per share on 31/01/2022: € 10.27]]></title>
                <link>https://capricorn.be/en/news_items/nav-per-share-on-31012022-eur-1027</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/564</guid>
                <pubDate>2022-02-10T16:39:30+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Acquisition of c-LEcta]]></title>
                <link>https://capricorn.be/en/news_items/acquisition-of-c-lecta-1</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/565</guid>
                <pubDate>2022-02-16T14:03:54+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Acquisition of c-LEcta]]></title>
                <link>https://capricorn.be/en/news_items/acquisition-of-c-lecta</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/566</guid>
                <pubDate>2022-03-01T08:49:27+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Brigitte de Vet-Veithen proposed as director of Quest for Growth]]></title>
                <link>https://capricorn.be/en/news_items/brigitte-de-vet-veithen-proposed-as-director-of-quest-for-growth</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/570</guid>
                <pubDate>2022-05-09T15:20:02+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Portfolio company Scaled Access acquired by OneWelcome, the Dutch Identity and Access Platform]]></title>
                <link>https://capricorn.be/en/news_items/portfolio-company-scaled-access-acquired-by-onewelcome-the-dutch-identity-and-access-platform</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/571</guid>
                <pubDate>2022-03-01T09:04:18+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Capricorn Digital Growth Fund has final closing at € 84.5 million]]></title>
                <link>https://capricorn.be/en/news_items/capricorn-digital-growth-fund-has-final-closing-at-eur-845-million</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/572</guid>
                <pubDate>2022-03-02T18:17:13+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[NAV per share on 28/02/2022: € 10.38]]></title>
                <link>https://capricorn.be/en/news_items/nav-per-share-on-28022022-eur-1038</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/573</guid>
                <pubDate>2022-03-03T17:39:12+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Toyobo invests in U.S. biotech startup DMC Biotechnologies Inc.]]></title>
                <link>https://capricorn.be/en/news_items/toyobo-invests-in-us-biotech-startup-dmc-biotechnologies-inc</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/574</guid>
                <pubDate>2022-03-14T10:27:15+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[DMC Appoints Kelly Smith as VP R&amp;D]]></title>
                <link>https://capricorn.be/en/news_items/dmc-appoints-kelly-smith-as-vp-rd</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/575</guid>
                <pubDate>2022-03-17T11:34:53+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Dividend and modalities for optional dividend approved]]></title>
                <link>https://capricorn.be/en/news_items/dividend-and-modalities-for-optional-dividend-approved</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/577</guid>
                <pubDate>2022-03-31T15:31:23+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[FEops HEARTguide receives FDA clearance for LAAo planning capabilities]]></title>
                <link>https://capricorn.be/en/news_items/feops-heartguide-receives-fda-clearance-for-laao-planning-capabilities</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/578</guid>
                <pubDate>2022-04-07T09:33:31+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[NAV per share on 31/03/2022: € 10.47]]></title>
                <link>https://capricorn.be/en/news_items/nav-per-share-on-31032022-eur-1047</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/579</guid>
                <pubDate>2022-04-07T10:08:07+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Result optional dividend: 45% of the dividend converted into new shares]]></title>
                <link>https://capricorn.be/en/news_items/result-optional-dividend-45-of-the-dividend-converted-into-new-shares</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/580</guid>
                <pubDate>2022-10-28T08:50:08+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Transparency legislation: disclosure of outstanding voting securities]]></title>
                <link>https://capricorn.be/en/news_items/transparency-legislation-disclosure-of-outstanding-voting-securities</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/581</guid>
                <pubDate>2022-04-27T09:01:46+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Econic Technologies raises funds for commercialisation with incoming investor Capricorn, and OGCI Climate Investments]]></title>
                <link>https://capricorn.be/en/news_items/econic-technologies-raises-funds-for-commercialisation-with-incoming-investor-capricorn-and-ogci-climate-investments</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/582</guid>
                <pubDate>2022-04-29T09:49:57+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Quest for Growth business update 31 March 2022]]></title>
                <link>https://capricorn.be/en/news_items/quest-for-growth-business-update-31-march-2022</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/583</guid>
                <pubDate>2022-04-28T14:56:21+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[NAV per share on 30/04/2022: € 8.99]]></title>
                <link>https://capricorn.be/en/news_items/nav-per-share-on-30042022-eur-899</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/585</guid>
                <pubDate>2022-05-05T10:28:30+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Capricorn Partners leads € 4 million round investing in French company Zozio to internationalize their digital platform for factory logistics]]></title>
                <link>https://capricorn.be/en/news_items/capricorn-partners-leads-eur-4-million-round-investing-in-french-company-zozio-to-internationalize-their-digital-platform-for-factory-logistics</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/586</guid>
                <pubDate>2022-05-10T12:02:03+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Rein4ced receives 12M€ funding to expand production of innovative bike frames]]></title>
                <link>https://capricorn.be/en/news_items/rein4ced-receives-12meur-funding-to-expand-production-of-innovative-bike-frames</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/587</guid>
                <pubDate>2022-05-19T11:49:29+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[NAV per share on 31/05/2022: € 8.71]]></title>
                <link>https://capricorn.be/en/news_items/nav-per-share-on-31052022-eur-871</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/588</guid>
                <pubDate>2022-06-02T11:23:58+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[VOID&#039;s VO+ white films offer improved recyclability]]></title>
                <link>https://capricorn.be/en/news_items/voids-vo-white-films-offer-improved-recyclability</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/589</guid>
                <pubDate>2022-06-07T12:15:52+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Tosca Group digitizes North American supply chain with help of Belgian Sensolus]]></title>
                <link>https://capricorn.be/en/news_items/tosca-group-digitizes-north-american-supply-chain-with-help-of-belgian-sensolus</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/590</guid>
                <pubDate>2022-06-13T10:36:15+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Econic and Changhua announce licensing agreement to develop and grow CO2-based polyurethanes in China]]></title>
                <link>https://capricorn.be/en/news_items/econic-and-changhua-announce-licensing-agreement-to-develop-and-grow-co2-based-polyurethanes-in-china</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/591</guid>
                <pubDate>2022-06-13T10:41:50+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[ViroVet completes series C funding]]></title>
                <link>https://capricorn.be/en/news_items/virovet-completes-series-c-funding</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/592</guid>
                <pubDate>2022-06-17T15:26:23+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Capricorn Fusion China Fund invests in Finquest]]></title>
                <link>https://capricorn.be/en/news_items/capricorn-fusion-china-fund-invests-in-finquest</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/593</guid>
                <pubDate>2022-06-24T12:16:32+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Quest for Growth invests in Finquest]]></title>
                <link>https://capricorn.be/en/news_items/quest-for-growth-invests-in-finquest</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/594</guid>
                <pubDate>2022-06-23T15:35:00+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[StoryChief raises a € 3.4 million round led by Capricorn Partners to scale their digital platform for content marketing and AI]]></title>
                <link>https://capricorn.be/en/news_items/storychief-raises-a-eur-34-million-round-led-by-capricorn-partners-to-scale-their-digital-platform-for-content-marketing-and-ai</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/595</guid>
                <pubDate>2022-07-18T10:15:45+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[NAV per share on 30/06/2022: € 8.49]]></title>
                <link>https://capricorn.be/en/news_items/nav-per-share-on-30062022-eur-849</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/596</guid>
                <pubDate>2022-07-07T14:55:58+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Thales further accelerates its cybersecurity development with the acquisition of OneWelcome, a leader in Customer Identity and Access Management]]></title>
                <link>https://capricorn.be/en/news_items/thales-further-accelerates-its-cybersecurity-development-with-the-acquisition-of-onewelcome-a-leader-in-customer-identity-and-access-management</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/597</guid>
                <pubDate>2022-07-12T11:41:00+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Manali Petrochemicals inks commercial agreement with UK-based Econic Technologies to manufacture eco-friendly polyols]]></title>
                <link>https://capricorn.be/en/news_items/manali-petrochemicals-inks-commercial-agreement-with-uk-based-econic-technologies-to-manufacture-eco-friendly-polyols</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/598</guid>
                <pubDate>2022-07-20T11:59:59+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Capricorn Health-tech Fund supports its portfolio company iSTAR Medical entering into a Strategic Alliance with AbbVie for the Treatment of Glaucoma]]></title>
                <link>https://capricorn.be/en/news_items/capricorn-health-tech-fund-supports-its-portfolio-company-istar-medical-entering-into-a-strategic-alliance-with-abbvie-for-the-treatment-of-glaucoma</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/599</guid>
                <pubDate>2022-07-20T14:26:08+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Semi-annual report 30 June 2022]]></title>
                <link>https://capricorn.be/en/news_items/semi-annual-report-30-june-2022</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/600</guid>
                <pubDate>2022-07-28T14:52:46+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[NAV per share on 31/07/2022: € 8.71]]></title>
                <link>https://capricorn.be/en/news_items/nav-per-share-on-31072022-eur-871</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/601</guid>
                <pubDate>2022-08-04T14:46:24+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Econic Technologies raises £ 10.4 million in a successful second close of its current funding round]]></title>
                <link>https://capricorn.be/en/news_items/econic-technologies-raises-ps-104-million-in-a-successful-second-close-of-its-current-funding-round</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/602</guid>
                <pubDate>2022-08-09T11:49:55+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[€ 10 million for Dutch scale-up Gradyent to make district heating systems more efficient and sustainable]]></title>
                <link>https://capricorn.be/en/news_items/eur-10-million-for-dutch-scale-up-gradyent-to-make-district-heating-systems-more-efficient-and-sustainable</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/603</guid>
                <pubDate>2022-08-16T09:41:55+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Launch of Capricorn Industrial Biotech Fund by DSM, InnovationQuarter and Capricorn Partners]]></title>
                <link>https://capricorn.be/en/news_items/launch-of-capricorn-industrial-biotech-fund-by-dsm-innovationquarter-and-capricorn-partners</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/604</guid>
                <pubDate>2022-09-01T08:53:17+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Partnership for the transport and logistics industry: Sensolus and Deutsche Telekom offer IoT-asset tracking as a joint effort]]></title>
                <link>https://capricorn.be/en/news_items/partnership-for-the-transport-and-logistics-industry-sensolus-and-deutsche-telekom-offer-iot-asset-tracking-as-a-joint-effort</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/605</guid>
                <pubDate>2022-09-02T10:19:10+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Trensition raises € 1.8 million through Ageas and Capricorn Partners to scale up its AI-driven strategic intelligence platform]]></title>
                <link>https://capricorn.be/en/news_items/trensition-raises-eur-18-million-through-ageas-and-capricorn-partners-to-scale-up-its-ai-driven-strategic-intelligence-platform</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/606</guid>
                <pubDate>2022-09-30T11:39:26+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[NAV per share on 31/08/2022: € 8.43]]></title>
                <link>https://capricorn.be/en/news_items/nav-per-share-on-31082022-eur-843</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/607</guid>
                <pubDate>2022-09-08T14:49:54+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Capricorn Partners leads Series A investment round of € 5.4 million in the Belgian company Bingli to further accelerate its AI-based smart medical interview]]></title>
                <link>https://capricorn.be/en/news_items/capricorn-partners-leads-series-a-investment-round-of-eur-54-million-in-the-belgian-company-bingli-to-further-accelerate-its-ai-based-smart-medical-interview</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/608</guid>
                <pubDate>2022-10-04T13:37:30+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[NAV per share on 30/09/2022: € 8.02]]></title>
                <link>https://capricorn.be/en/news_items/nav-per-share-on-30092022-eur-802</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/609</guid>
                <pubDate>2022-10-06T13:58:26+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Capricorn Partners expands its Board and Executive Committee]]></title>
                <link>https://capricorn.be/en/news_items/capricorn-partners-expands-its-board-and-executive-committee</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/610</guid>
                <pubDate>2022-10-06T17:15:10+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Indigo Diabetes Announces First Participant Enrolled in the SHINE Clinical Trial]]></title>
                <link>https://capricorn.be/en/news_items/indigo-diabetes-announces-first-participant-enrolled-in-the-shine-clinical-trial</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/611</guid>
                <pubDate>2022-10-10T10:43:52+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Business update 30 September 2022]]></title>
                <link>https://capricorn.be/en/news_items/business-update-30-september-2022</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/612</guid>
                <pubDate>2022-10-27T15:55:03+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[FEops secures additional capital from the EIC Fund]]></title>
                <link>https://capricorn.be/en/news_items/feops-secures-additional-capital-from-the-eic-fund</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/613</guid>
                <pubDate>2022-10-31T10:08:07+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Indigo Diabetes incorporates fully owned subsidiary in the US and appoints Peter J. Devlin as President, Indigo Medical US Inc.]]></title>
                <link>https://capricorn.be/en/news_items/indigo-diabetes-incorporates-fully-owned-subsidiary-in-the-us-and-appoints-peter-j-devlin-as-president-indigo-medical-us-inc</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/614</guid>
                <pubDate>2022-10-31T10:25:43+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[NAV per share on 31/10/2022: € 8.13]]></title>
                <link>https://capricorn.be/en/news_items/nav-per-share-on-31102022-eur-813</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/615</guid>
                <pubDate>2022-11-03T10:43:43+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Capricorn Partners joins in a € 10 million Pre-Series A financing round in neotiv to accelerate Alzheimer’s diagnosis]]></title>
                <link>https://capricorn.be/en/news_items/capricorn-partners-joins-in-a-eur-10-million-pre-series-a-financing-round-in-neotiv-to-accelerate-alzheimers-diagnosis</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/616</guid>
                <pubDate>2022-11-09T10:27:09+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Filip Pintelon to represent Capricorn on the board of iSTAR Medical]]></title>
                <link>https://capricorn.be/en/news_items/filip-pintelon-to-represent-capricorn-on-the-board-of-istar-medical</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/617</guid>
                <pubDate>2022-12-08T11:24:37+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Belgian company Minze Health raises € 3.9 million to further scale its digital health solutions for the treatment of urinary tract problems]]></title>
                <link>https://capricorn.be/en/news_items/belgian-company-minze-health-raises-eur-39-million-to-further-scale-its-digital-health-solutions-for-the-treatment-of-urinary-tract-problems</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/618</guid>
                <pubDate>2022-12-01T10:58:35+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Our portfolio company, Trillium announces close of Series A financing, raising US$ 10.6 million]]></title>
                <link>https://capricorn.be/en/news_items/our-portfolio-company-trillium-announces-close-of-series-a-financing-raising-us-106-million</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/619</guid>
                <pubDate>2022-12-07T14:33:28+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Capricorn Fusion China Fund invests in fruitcore robotics]]></title>
                <link>https://capricorn.be/en/news_items/capricorn-fusion-china-fund-invests-in-fruitcore-robotics</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/620</guid>
                <pubDate>2022-12-14T13:45:45+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[NAV per share on 30/11/2022: € 8.36]]></title>
                <link>https://capricorn.be/en/news_items/nav-per-share-on-30112022-eur-836</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/621</guid>
                <pubDate>2022-12-08T10:22:40+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Quest for Growth invests in fruitcore robotics]]></title>
                <link>https://capricorn.be/en/news_items/quest-for-growth-invests-in-fruitcore-robotics</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/622</guid>
                <pubDate>2022-12-14T13:42:07+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[NAV per share on 31/12/2022: € 7.93]]></title>
                <link>https://capricorn.be/en/news_items/nav-per-share-on-31122022-eur-793</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/623</guid>
                <pubDate>2023-01-04T15:16:47+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[FEops appoints Euan S. Thomson, PhD as Board Chair in support of expanding digital health goals]]></title>
                <link>https://capricorn.be/en/news_items/feops-appoints-euan-s-thomson-phd-as-board-chair-in-support-of-expanding-digital-health-goals</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/624</guid>
                <pubDate>2023-01-12T16:07:19+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Chainels secures € 3 million Series A investment to enhance visibility in the European proptech market]]></title>
                <link>https://capricorn.be/en/news_items/chainels-secures-eur-3-million-series-a-investment-to-enhance-visibility-in-the-european-proptech-market</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/625</guid>
                <pubDate>2023-01-24T11:20:54+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Quest for Growth suffers a € 25 million loss in 2022 following three robust years]]></title>
                <link>https://capricorn.be/en/news_items/quest-for-growth-suffers-a-eur-25-million-loss-in-2022-following-three-robust-years</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/626</guid>
                <pubDate>2023-01-26T09:24:25+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[NAV per share on 31/01/2023]]></title>
                <link>https://capricorn.be/en/news_items/nav-per-share-on-31012023</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/627</guid>
                <pubDate>2023-02-01T12:04:15+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[New Board of Directors with as many women as men]]></title>
                <link>https://capricorn.be/en/news_items/new-board-of-directors-with-as-many-women-as-men</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/628</guid>
                <pubDate>2023-02-24T11:29:33+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Confo Therapeutics Announces Global Licensing Agreement with Lilly for Peripheral Pain Candidate, CFTX-1554]]></title>
                <link>https://capricorn.be/en/news_items/confo-therapeutics-announces-global-licensing-agreement-with-lilly-for-peripheral-pain-candidate-cftx-1554</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/629</guid>
                <pubDate>2023-03-02T16:15:43+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[NAV per share on 28/02/2023: € 8.25]]></title>
                <link>https://capricorn.be/en/news_items/nav-per-share-on-28022023-eur-825</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/630</guid>
                <pubDate>2023-03-01T15:01:18+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Confo Therapeutics enters into collaboration agreement with Daiichi Sankyo to discover novel medicines for CNS diseases]]></title>
                <link>https://capricorn.be/en/news_items/confo-therapeutics-enters-into-collaboration-agreement-with-daiichi-sankyo-to-discover-novel-medicines-for-cns-diseases</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/632</guid>
                <pubDate>2023-03-30T16:08:19+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[NAV per share on 31/03/2023: € 7.98]]></title>
                <link>https://capricorn.be/en/news_items/nav-per-share-on-31032023-eur-798</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/633</guid>
                <pubDate>2023-04-06T11:31:07+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Business update 31 March 2023]]></title>
                <link>https://capricorn.be/en/news_items/business-update-31-march-2023</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/634</guid>
                <pubDate>2023-04-27T13:18:35+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[NAV per share on 30/04/2023: € 7.88]]></title>
                <link>https://capricorn.be/en/news_items/nav-per-share-on-30042023-eur-788</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/635</guid>
                <pubDate>2023-05-03T13:49:23+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Indigo appoints Dr Arun Venkatasubramanian as Chief Technology Officer]]></title>
                <link>https://capricorn.be/en/news_items/indigo-appoints-dr-arun-venkatasubramanian-as-chief-technology-officer</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/636</guid>
                <pubDate>2023-05-10T13:52:17+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[VoxelSensors raises € 5 million in seed funding for blending the physical and digital worlds through 3D perception]]></title>
                <link>https://capricorn.be/en/news_items/voxelsensors-raises-eur-5-million-in-seed-funding-for-blending-the-physical-and-digital-worlds-through-3d-perception</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/637</guid>
                <pubDate>2023-05-17T16:29:36+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Transparency legislation]]></title>
                <link>https://capricorn.be/en/news_items/transparency-legislation</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/638</guid>
                <pubDate>2023-05-25T10:21:01+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[NAV per share on 31/05/2023: € 7.87]]></title>
                <link>https://capricorn.be/en/news_items/nav-per-share-on-31052023-eur-787</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/639</guid>
                <pubDate>2023-06-08T10:40:39+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Econic Technologies and Monument Chemical announce licensing agreement to develop and grow CO2 based polyurethanes in USA]]></title>
                <link>https://capricorn.be/en/news_items/econic-technologies-and-monument-chemical-announce-licensing-agreement-to-develop-and-grow-co2-based-polyurethanes-in-usa</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/640</guid>
                <pubDate>2023-06-21T13:41:50+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[AMA issues CPT III code for icometrix’ AI-related brain MRI quantification software]]></title>
                <link>https://capricorn.be/en/news_items/ama-issues-cpt-iii-code-for-icometrix-ai-related-brain-mri-quantification-software</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/641</guid>
                <pubDate>2023-06-29T17:07:35+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[NAV per share on 30/06/2023: € 7.78]]></title>
                <link>https://capricorn.be/en/news_items/nav-per-share-on-30062023-eur-778</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/642</guid>
                <pubDate>2023-07-06T10:23:15+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Qpinch: revolutionizing industrial energy efficiency]]></title>
                <link>https://capricorn.be/en/news_items/qpinch-revolutionizing-industrial-energy-efficiency</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/643</guid>
                <pubDate>2023-07-26T11:54:20+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Semi-annual report 30 June 2023]]></title>
                <link>https://capricorn.be/en/news_items/semi-annual-report-30-june-2023</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/644</guid>
                <pubDate>2023-07-27T10:20:03+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[NAV per share on 31/07/2023: € 7.83]]></title>
                <link>https://capricorn.be/en/news_items/nav-per-share-on-31072023-eur-783</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/645</guid>
                <pubDate>2023-08-02T15:05:41+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Capricorn Partners ready for the future]]></title>
                <link>https://capricorn.be/en/news_items/capricorn-partners-ready-for-the-future</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/647</guid>
                <pubDate>2023-09-01T14:05:45+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[NAV per share on 31/08/2023: € 7.66]]></title>
                <link>https://capricorn.be/en/news_items/nav-per-share-on-31082023-eur-766</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/648</guid>
                <pubDate>2023-09-07T14:48:02+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[NAV per share on 30/09/2023: €7.41]]></title>
                <link>https://capricorn.be/en/news_items/nav-per-share-on-30092023-eur741</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/649</guid>
                <pubDate>2023-10-05T10:14:45+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Business update 30 September 2023]]></title>
                <link>https://capricorn.be/en/news_items/business-update-30-september-2023</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/650</guid>
                <pubDate>2023-10-26T13:47:47+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[NAV per share on 31/10/2023: €7.14]]></title>
                <link>https://capricorn.be/en/news_items/nav-per-share-on-31102023-eur714</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/651</guid>
                <pubDate>2023-11-08T15:08:02+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[NAV per share on 30/11/2023: €7.36]]></title>
                <link>https://capricorn.be/en/news_items/nav-per-share-on-30112023-eur736</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/652</guid>
                <pubDate>2023-12-07T09:18:23+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[NAV per share on 31/12/2023: €7.51]]></title>
                <link>https://capricorn.be/en/news_items/nav-per-share-on-31122023-eur751</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/653</guid>
                <pubDate>2024-01-04T09:43:50+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Lieve Creten new chairman board of directors]]></title>
                <link>https://capricorn.be/en/news_items/lieve-creten-new-chairman-board-of-directors</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/654</guid>
                <pubDate>2024-04-26T11:08:06+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Slight loss for Quest for Growth in 2023]]></title>
                <link>https://capricorn.be/en/news_items/slight-loss-for-quest-for-growth-in-2023</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/655</guid>
                <pubDate>2024-01-25T13:31:24+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[VoxelSensors completes its Seed Round with an additional € 3 million, totaling € 9.5 million for XR and Mobile Spatial and Empathic Computing]]></title>
                <link>https://capricorn.be/en/news_items/voxelsensors-completes-its-seed-round-with-an-additional-eur-3-million-totaling-eur-95-million-for-xr-and-mobile-spatial-and-empathic-computing</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/656</guid>
                <pubDate>2024-01-31T09:42:34+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[NEFFA | New Fashion Factory secures Seed funding, spearheaded by the Capricorn Industrial Biotech Fund]]></title>
                <link>https://capricorn.be/en/news_items/neffa-new-fashion-factory-secures-seed-funding-spearheaded-by-the-capricorn-industrial-biotech-fund</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/657</guid>
                <pubDate>2024-02-05T17:17:59+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[NAV per share on 31/01/2024: €7.43]]></title>
                <link>https://capricorn.be/en/news_items/nav-per-share-on-31012024-eur743</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/658</guid>
                <pubDate>2024-02-08T09:30:15+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[VoxelSensors expands its Spatial and Empathic Computing Solutions, with Gaze Tracking, Acquires EyeWay Vision’s IP, and Unveils the Plan for its First Spatial Awareness System for Mobile]]></title>
                <link>https://capricorn.be/en/news_items/voxelsensors-expands-its-spatial-and-empathic-computing-solutions-with-gaze-tracking-acquires-eyeway-visions-ip-and-unveils-the-plan-for-its-first-spatial-awareness-system-for-mobile</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/659</guid>
                <pubDate>2024-02-26T15:40:43+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[NAV per share on 29/02/2024: €7.46]]></title>
                <link>https://capricorn.be/en/news_items/nav-per-share-on-29022024-eur746</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/660</guid>
                <pubDate>2024-03-07T09:42:07+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[NAV per share on 31/03/2024: € 7.44]]></title>
                <link>https://capricorn.be/en/news_items/nav-per-share-on-31032024-eur-744</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/661</guid>
                <pubDate>2024-04-04T09:31:58+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Business update 31 March 2024]]></title>
                <link>https://capricorn.be/en/news_items/business-update-31-march-2024</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/662</guid>
                <pubDate>2024-04-25T11:08:28+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[NAV per share on 30/04: € 7.44]]></title>
                <link>https://capricorn.be/en/news_items/nav-per-share-on-3004-eur-744</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/663</guid>
                <pubDate>2024-05-08T09:48:40+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Revolutionizing Energy Efficiency for the Industry: Qpinch Secures Capital Increase for Innovative Heat Transforming Technology to Decarbonize Industrial Heat Production]]></title>
                <link>https://capricorn.be/en/news_items/revolutionizing-energy-efficiency-for-the-industry-qpinch-secures-capital-increase-for-innovative-heat-transforming-technology-to-decarbonize-industrial-heat-production</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/664</guid>
                <pubDate>2024-05-28T11:13:07+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Trillium Renewable Chemicals selects INEOS Green Lake for world’s first demonstration plant for sustainable acrylonitrile production]]></title>
                <link>https://capricorn.be/en/news_items/trillium-renewable-chemicals-selects-ineos-green-lake-for-worlds-first-demonstration-plant-for-sustainable-acrylonitrile-production</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/665</guid>
                <pubDate>2024-06-06T09:17:18+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[NAV per share on 31/05/2024 : € 7.62]]></title>
                <link>https://capricorn.be/en/news_items/nav-per-share-on-31052024-eur-762</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/666</guid>
                <pubDate>2024-06-06T09:35:58+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[NAV per share on 30/06/2024: € 7.41]]></title>
                <link>https://capricorn.be/en/news_items/nav-per-share-on-30062024-eur-741</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/667</guid>
                <pubDate>2024-07-03T09:57:58+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[ExCulture secures funding from the Dutch Industrial Biotech Seed Fund (managed by Capricorn Partners) and TTT Medtech]]></title>
                <link>https://capricorn.be/en/news_items/exculture-secures-funding-from-the-dutch-industrial-biotech-seed-fund-managed-by-capricorn-partners-and-ttt-medtech</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/668</guid>
                <pubDate>2024-07-12T13:52:50+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Our portfolio company FEops joins forces with Materialise]]></title>
                <link>https://capricorn.be/en/news_items/our-portfolio-company-feops-joins-forces-with-materialise</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/669</guid>
                <pubDate>2024-07-18T17:48:16+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Semi-annual report 30 June 2024]]></title>
                <link>https://capricorn.be/en/news_items/semi-annual-report-30-june-2024</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/670</guid>
                <pubDate>2024-07-25T10:51:38+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Quest for Growth participates in € 60 million funding round for Confo Therapeutics, advancing innovative therapies]]></title>
                <link>https://capricorn.be/en/news_items/quest-for-growth-participates-in-eur-60-million-funding-round-for-confo-therapeutics-advancing-innovative-therapies</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/671</guid>
                <pubDate>2024-07-25T13:49:42+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Confo Therapeutics Announces € 60 million Series B Financing to advance pipeline of novel GPCR-Modulating Therapies into clinical development]]></title>
                <link>https://capricorn.be/en/news_items/confo-therapeutics-announces-eur-60-million-series-b-financing-to-advance-pipeline-of-novel-gpcr-modulating-therapies-into-clinical-development</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/672</guid>
                <pubDate>2024-07-26T06:56:26+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[NAV per share on 31/07/2024: € 7.46]]></title>
                <link>https://capricorn.be/en/news_items/nav-per-share-on-31072024-eur-746</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/673</guid>
                <pubDate>2024-08-08T14:48:40+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Thryve secures € 4 million funding to accelerate international growth]]></title>
                <link>https://capricorn.be/en/news_items/thryve-secures-eur-4-million-funding-to-accelerate-international-growth</link>
                <description><![CDATA[Expanding its wearable integration for automated prevention and treatment]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/674</guid>
                <pubDate>2024-09-02T08:29:52+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[NAV per share on 31/08/2024: € 7.45]]></title>
                <link>https://capricorn.be/en/news_items/nav-per-share-on-31082024-eur-745</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/677</guid>
                <pubDate>2024-09-04T14:48:52+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[NAV per share on 30/09/2024: € 7.37]]></title>
                <link>https://capricorn.be/en/news_items/nav-per-share-on-30092024-eur-737</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/679</guid>
                <pubDate>2024-10-02T14:09:16+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Minze Health raises US$ 5.3 million in funding to develop Prescription Digital Therapeutics and Drive Commercialization in the US Market]]></title>
                <link>https://capricorn.be/en/news_items/minze-health-raises-us-53-million-in-funding-to-develop-prescription-digital-therapeutics-and-drive-commercialization-in-the-us-market</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/680</guid>
                <pubDate>2024-10-17T13:39:44+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Capricorn Partners supports Econic as it welcomes new investment to accelerate CO₂ polyols and surfactants]]></title>
                <link>https://capricorn.be/en/news_items/capricorn-partners-supports-econic-as-it-welcomes-new-investment-to-accelerate-co2-polyols-and-surfactants</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/681</guid>
                <pubDate>2024-10-17T13:35:57+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Business update 30 September 2024]]></title>
                <link>https://capricorn.be/en/news_items/business-update-30-september-2024</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/682</guid>
                <pubDate>2024-10-24T11:22:09+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[NAV per share on 31/10/2024: € 7.19]]></title>
                <link>https://capricorn.be/en/news_items/nav-per-share-on-31102024-eur-719</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/683</guid>
                <pubDate>2024-11-07T10:32:56+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Takeover bid on Nexus AG, a stock from QfG’s portfolio]]></title>
                <link>https://capricorn.be/en/news_items/takeover-bid-on-nexus-ag-a-stock-from-qfgs-portfolio</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/684</guid>
                <pubDate>2024-11-27T10:39:01+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[NAV per share on 30/11/2024: € 7.11]]></title>
                <link>https://capricorn.be/en/news_items/nav-per-share-on-30112024-eur-711</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/685</guid>
                <pubDate>2024-12-05T14:13:16+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Capricorn Partners launches the Capricorn Healthtech Fund II with a first closing of €51 million]]></title>
                <link>https://capricorn.be/en/news_items/capricorn-partners-launches-the-capricorn-healthtech-fund-ii-with-a-first-closing-of-eur51-million</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/687</guid>
                <pubDate>2025-01-09T07:52:08+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[QfG commits € 12.5 million to Capricorn Healthtech Fund II]]></title>
                <link>https://capricorn.be/en/news_items/qfg-commits-eur-125-million-to-capricorn-healthtech-fund-ii</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/688</guid>
                <pubDate>2025-01-09T09:53:43+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[NAV per share on 31/12/2024: € 7.17]]></title>
                <link>https://capricorn.be/en/news_items/nav-per-share-on-31122024-eur-717</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/689</guid>
                <pubDate>2025-01-09T11:13:23+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Funding for InsectSense to further improve objective taste measurement]]></title>
                <link>https://capricorn.be/en/news_items/funding-for-insectsense-to-further-improve-objective-taste-measurement</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/690</guid>
                <pubDate>2025-01-16T14:05:08+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Quest for Growth cannot yet turn the tide in 2024]]></title>
                <link>https://capricorn.be/en/news_items/quest-for-growth-cannot-yet-turn-the-tide-in-2024</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/691</guid>
                <pubDate>2025-01-31T15:24:55+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[NAV per share on 31/01/2025: € 7.27]]></title>
                <link>https://capricorn.be/en/news_items/nav-per-share-on-31012025-eur-727</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/692</guid>
                <pubDate>2025-02-06T10:10:29+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[NAV per share on 28/02/2025: € 7.30]]></title>
                <link>https://capricorn.be/en/news_items/nav-per-share-on-28022025-eur-730</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/693</guid>
                <pubDate>2025-03-06T15:09:34+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Gradyent secures € 28 million to optimise and transform heating and cooling grids]]></title>
                <link>https://capricorn.be/en/news_items/gradyent-secures-eur-28-million-to-optimise-and-transform-heating-and-cooling-grids</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/694</guid>
                <pubDate>2025-04-02T09:06:21+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[NAV per share on 31/03/2025: € 7.18]]></title>
                <link>https://capricorn.be/en/news_items/nav-per-share-on-31032025-eur-718</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/695</guid>
                <pubDate>2025-04-03T10:38:54+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Business update  31 March 2025]]></title>
                <link>https://capricorn.be/en/news_items/business-update-31-march-2025</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/696</guid>
                <pubDate>2025-04-24T11:10:09+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[NAV per share on 30/04/2025: € 7.12]]></title>
                <link>https://capricorn.be/en/news_items/nav-per-share-on-30042025-eur-712</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/697</guid>
                <pubDate>2025-05-08T10:11:54+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[DMC Launches Fermented Myo-Inositol, a Cleaner and more Sustainable Alternative, Benefiting Metabolic, Reproductive, and Infant Health markets]]></title>
                <link>https://capricorn.be/en/news_items/dmc-launches-fermented-myo-inositol-a-cleaner-and-more-sustainable-alternative-benefiting-metabolic-reproductive-and-infant-health-markets</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/698</guid>
                <pubDate>2025-05-21T14:08:47+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[DMC Launches appoints Industry Veteran K’Lynne Johnson as Chair of the Board]]></title>
                <link>https://capricorn.be/en/news_items/dmc-launches-appoints-industry-veteran-klynne-johnson-as-chair-of-the-board</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/699</guid>
                <pubDate>2025-05-21T14:24:57+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Toyobo and DMC Biotechnologies Sign Joint Development Agreement to Advance Sustainable Chemical Solutions]]></title>
                <link>https://capricorn.be/en/news_items/toyobo-and-dmc-biotechnologies-sign-joint-development-agreement-to-advance-sustainable-chemical-solutions</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/700</guid>
                <pubDate>2025-06-04T08:35:57+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[NAV per share on 31/05/2025: € 7.44]]></title>
                <link>https://capricorn.be/en/news_items/nav-per-share-on-31052025-eur-744</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/701</guid>
                <pubDate>2025-06-05T09:04:20+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Econic Launches RecreaireTM Carbonate Ethoxylates Made From CO2]]></title>
                <link>https://capricorn.be/en/news_items/econic-launches-recreairetm-carbonate-ethoxylates-made-from-co2</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/702</guid>
                <pubDate>2025-06-10T15:40:56+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Belfius lnsurance has the intention to sell its stake in Quest for Growth]]></title>
                <link>https://capricorn.be/en/news_items/belfius-lnsurance-has-the-intention-to-sell-its-stake-in-quest-for-growth</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/703</guid>
                <pubDate>2025-07-07T14:37:02+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Jos B Peeters and Philippe Haspeslagh  acquire the stake of Belfius Insurance in Quest for Growth]]></title>
                <link>https://capricorn.be/en/news_items/jos-b-peeters-and-philippe-haspeslagh-acquire-the-stake-of-belfius-insurance-in-quest-for-growth</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/704</guid>
                <pubDate>2025-07-07T14:36:37+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[NAV per share on 30/06/2025: € 7.38]]></title>
                <link>https://capricorn.be/en/news_items/nav-per-share-on-30062025-eur-738</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/705</guid>
                <pubDate>2025-07-03T10:46:55+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Disclosure of modifications in significant shareholdings according to the Transparency Law of 2 May 2007]]></title>
                <link>https://capricorn.be/en/news_items/disclosure-of-modifications-in-significant-shareholdings-according-to-the-transparency-law-of-2-may-2007</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/706</guid>
                <pubDate>2025-07-08T15:52:59+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[DMC Debuts Industry-First Fermented D-Chiro-Inositol, Raising the Bar with a Cleaner and More Sustainable Nutraceutical Ingredient]]></title>
                <link>https://capricorn.be/en/news_items/dmc-debuts-industry-first-fermented-d-chiro-inositol-raising-the-bar-with-a-cleaner-and-more-sustainable-nutraceutical-ingredient</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/707</guid>
                <pubDate>2025-07-16T16:55:37+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Semi-annual report 30 June 2025]]></title>
                <link>https://capricorn.be/en/news_items/semi-annual-report-30-june-2025</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/708</guid>
                <pubDate>2025-07-31T17:59:35+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[NAV per share on 31/07/2025: € 7.52]]></title>
                <link>https://capricorn.be/en/news_items/nav-per-share-on-31072025-eur-752</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/709</guid>
                <pubDate>2025-08-07T10:30:41+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[NAV per share on 31/08/2025: € 7.43]]></title>
                <link>https://capricorn.be/en/news_items/nav-per-share-on-31082025-eur-743</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/710</guid>
                <pubDate>2025-09-04T10:44:37+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Capricorn Healthtech Fund II kicks off with first investment in Aspect Analytics’ € 10 million Series A round]]></title>
                <link>https://capricorn.be/en/news_items/capricorn-healthtech-fund-ii-kicks-off-with-first-investment-in-aspect-analytics-eur-10-million-series-a-round</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/711</guid>
                <pubDate>2025-09-09T08:56:58+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[VoxelSensors to advance next-generation Depth Sensing Technology with 10x power savings for XR applications]]></title>
                <link>https://capricorn.be/en/news_items/voxelsensors-to-advance-next-generation-depth-sensing-technology-with-10x-power-savings-for-xr-applications</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/712</guid>
                <pubDate>2025-09-08T16:49:01+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[NAV per share on 30/09/2025: € 7.21]]></title>
                <link>https://capricorn.be/en/news_items/nav-per-share-on-30092025-eur-721</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/714</guid>
                <pubDate>2025-10-09T10:38:43+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[VoxelSensors and Summer Robotics Partner to Revolutionize Robotics and Physically Intelligent AI during Belgian Economic Mission to the USA 2025]]></title>
                <link>https://capricorn.be/en/news_items/voxelsensors-and-summer-robotics-partner-to-revolutionize-robotics-and-physically-intelligent-ai-during-belgian-economic-mission-to-the-usa-2025</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/715</guid>
                <pubDate>2025-10-16T10:39:02+02:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[DAB.bio secures funding for its commercialization phase]]></title>
                <link>https://capricorn.be/en/news_items/dabbio-secures-funding-for-its-commercialization-phase</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/716</guid>
                <pubDate>2025-10-28T08:45:27+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[QfG strategic change of course and capital reduction]]></title>
                <link>https://capricorn.be/en/news_items/qfg-strategic-change-of-course-and-capital-reduction</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/717</guid>
                <pubDate>2025-10-28T15:15:53+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Business update 30 September 2025]]></title>
                <link>https://capricorn.be/en/news_items/business-update-30-september-2025</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/718</guid>
                <pubDate>2025-10-30T11:17:15+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Selectum Asset Management to become new investment manager of Quest Cleantech Fund - SICAV]]></title>
                <link>https://capricorn.be/en/news_items/selectum-asset-management-to-become-new-investment-manager-of-quest-cleantech-fund-sicav</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/719</guid>
                <pubDate>2025-11-04T15:08:40+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[NAV per share on 31/10/2025: € 7.31]]></title>
                <link>https://capricorn.be/en/news_items/nav-per-share-on-31102025-eur-731</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/720</guid>
                <pubDate>2025-11-06T13:54:23+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Azumuta Raises € 8 million Series A to Accelerate Digitalization and AI-Supported Work Instructions in Manufacturing]]></title>
                <link>https://capricorn.be/en/news_items/azumuta-raises-eur-8-million-series-a-to-accelerate-digitalization-and-ai-supported-work-instructions-in-manufacturing</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/721</guid>
                <pubDate>2025-11-13T08:32:06+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Capricorn Healthtech Fund II boosted by Dutch Partners]]></title>
                <link>https://capricorn.be/en/news_items/capricorn-healthtech-fund-ii-boosted-by-dutch-partners</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/722</guid>
                <pubDate>2025-11-12T13:11:24+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[NAV per share on 30/11/2025: € 7.29]]></title>
                <link>https://capricorn.be/en/news_items/nav-per-share-on-30112025-eur-729</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/723</guid>
                <pubDate>2025-12-04T11:46:09+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Trendtracker secures $7 million in Series A funding to scale its AI-powered strategic intelligence platform for global enterprises]]></title>
                <link>https://capricorn.be/en/news_items/trendtracker-secures-7-million-in-series-a-funding-to-scale-its-ai-powered-strategic-intelligence-platform-for-global-enterprises</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/724</guid>
                <pubDate>2025-12-10T16:41:53+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[NAV per share on 31/12/2025: € 7.09]]></title>
                <link>https://capricorn.be/en/news_items/nav-per-share-on-31122025-eur-709</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/725</guid>
                <pubDate>2026-01-08T10:51:42+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Announcement of capital distribution date]]></title>
                <link>https://capricorn.be/en/news_items/announcement-of-capital-distribution-date</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/726</guid>
                <pubDate>2026-02-12T11:18:12+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[QfG annual results 2025]]></title>
                <link>https://capricorn.be/en/news_items/qfg-annual-results-2025</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/727</guid>
                <pubDate>2026-01-29T09:40:06+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[NAV per share on 31/01/2026: € 6.99]]></title>
                <link>https://capricorn.be/en/news_items/nav-per-share-on-31012026-eur-699</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/728</guid>
                <pubDate>2026-02-05T09:39:22+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Medtech innovator Xyall closes € 7.6 million financing round to globally roll out its unique high-tech molecular pathology laboratory solutions]]></title>
                <link>https://capricorn.be/en/news_items/medtech-innovator-xyall-closes-eur-76-million-financing-round-to-globally-roll-out-its-unique-high-tech-molecular-pathology-laboratory-solutions</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/729</guid>
                <pubDate>2026-02-12T13:54:37+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Aestuarium: a new investment by Capricorn Industrial Biotech Fund]]></title>
                <link>https://capricorn.be/en/news_items/aestuarium-a-new-investment-by-capricorn-industrial-biotech-fund</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/730</guid>
                <pubDate>2026-02-12T17:30:00+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Capricorn Partners and Swiss Health Co-Lead €11M Round to Scale AI-Hybrid Care Platform Oska Health Across Europe]]></title>
                <link>https://capricorn.be/en/news_items/capricorn-partners-and-swiss-health-co-lead-eur11m-round-to-scale-ai-hybrid-care-platform-oska-health-across-europe</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/731</guid>
                <pubDate>2026-02-26T08:59:42+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[NAV per share on 28/02/2026: € 6.98]]></title>
                <link>https://capricorn.be/en/news_items/nav-per-share-on-28022026-eur-698</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/732</guid>
                <pubDate>2026-03-05T10:11:21+01:00</pubDate>
                            </item>
                    <item>
                <title><![CDATA[Changhua begins commercial production of CO2 Polyols based on Econic’s technology]]></title>
                <link>https://capricorn.be/en/news_items/changhua-begins-commercial-production-of-co2-polyols-based-on-econics-technology</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[news_items.feed author]]></author>
                <guid>https://capricorn.be/733</guid>
                <pubDate>2026-03-24T13:58:11+01:00</pubDate>
                            </item>
            </channel>
</rss>
